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Temporal lobe epilepsy (TLE) is the most common form of epilepsy. In many cases, patients with 
TLE are resistant to antiepileptic drugs. Therefore, it is imperative to unravel the underlying molecular 
mechanisms that are the cause and/or consequence of the disease to find new strategies to fight it.  
Synaptic plasticity is the ability of synapses to strengthen or weaken the communication efficiency 
in response to transient variations in their activity. Studies in the pilocarpine rat model of TLE indicate 
that neuronal hyperactivity in epilepsy is associated with abnormal synaptic plasticity, involving 
molecular changes in α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), in 
voltage-gated potassium channels Kv4.2, and post-synaptic proteins, post-synaptic protein 95 (PSD-95) 
and gephyrin.  
Remodelling of lipid raft composition is believed to contribute to altered cognition and synaptic 
plasticity observed upon ageing and neurodegenerative diseases. However, it is still unknown if such 
changes contribute to the cognitive decline and altered synaptic plasticity observed in TLE. 
In this thesis, an initial study was performed to evaluate changes in Kv4.2. channel levels and its 
phosphorylation in Thr602, Thr607 and Ser438 observed in non-pathological long-term-potentiation (LTP; 
a type of synaptic plasticity) induced by a moderate θ-burst stimulation and their relation to PSD-95 and 
synaptosomal nerve-associated protein 25 (SNAP-25) levels was evaluated by western-blot in 
hippocampal membranes obtained from stimulated and control slices. As expected, PSD-95 and SNAP-
25 levels did not change, but the levels of Kv4.2 channel and its phosphorylation at Ser438 and Thr602 
increased following LTP induction, while phosphorylation at Thr607 did not change. These results 
suggest a possible role for Kv4.2 channels in LTP expression even with mild θ-burst stimulation 
patterns, through phosphorylation at Ser438 and Thr602 residues.  
The main objective of this work was to unravel molecular mechanisms underlying TLE regarding 
the role of lipid raft changes in abnormal synaptic plasticity observed in TLE. For that, several 
approaches were used to characterize the chronic period of the Li2+-pilocarpine model of TLE in the rat. 
First, histochemistry was performed in hippocampal slices from 12-month-old Wistar rats exhibiting 
long-term spontaneous recurrent seizures (SRSs) and Sham controls to evaluate anatomical changes in 
this tissue. In SRS animals, NeuN immunolabelling revealed a decrease in neurons in the pyramidal cell 
layer of CA1 and CA3 and in the hilus of the dentate gyrus (DG). Changes in the architecture of the 
granule cell layer of the DG were also detected for NeuN immunolabelling and Nissl-staining. Finally, 
using Timm-staining it was possible to detect mossy fibre sprouting. These findings show that the DG 
is the hippocampal region that suffers more damage in this model.  
Molecular changes related to synaptic plasticity were studied by performing western-blot in 
hippocampal membranes isolated from SRS and Sham rats to evaluate: GluA1 and GluA2 AMPARs 
subunit levels, GluA1 phosphorylation in Ser831 and Ser845 and Kv4.2 channel expression; in addition, 
molecular changes related to profound changes in synaptic architecture were studied by targeting 
postsynaptic proteins PSD-95 and gephyrin and the presynaptic marker SNAP-25; finally, changes in 
planar lipid rafts and caveolae scaffolding proteins, flotillin-1 and caveolin-1 respectively, were 
monitored. The GluA1 and GluA2 subunit and PSD-95 levels decreased while the GluA1/GluA2 ratio, 
GluA1 phosphorylation in Ser831 and Ser845, along with gephyrin and caveolin-1 levels increased in SRS 
animals. SNAP-25, Kv4.2 channel and flotillin-1 levels did not change.  
To initiate the biophysical study of lipid rafts in model membranes obtained from synaptic lipids 
from the Li2+-pilocarpine rat model of TLE, the biophysical imaging and quantification of lipid rafts in 
giant unilamellar vesicles obtained from binary and ternary artificial lipid mixtures was performed. 
Giant unilamellar vesicles preparation by electroformation was optimized with success.  
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Changes found for AMPARs subunit stoichiometry and phosphorylation contribute to an increase 
in synaptic transmission that surely contributes to enhancement of neuronal excitability, and to 
progression of the disease. A decrease in PSD-95 and gephyrin suggests that excitatory transmission is 
down-regulated and inhibitory transmission is up-regulated, contributing to lower neuronal excitability, 
hinting on an adaptive molecular mechanism that is trying to counteract the hyperexcitability that 
characterizes epilepsy. The increase found for caveolin-1 suggests a new role for this protein in TLE, 
that is probably neuroprotection, as it occurs in other diseases.  
 





A epilepsia do lobo temporal (do inglês, TLE) é o tipo de epilepsia mais comum. Na maioria dos 
casos os pacientes com TLE são resistentes ao tratamento com fármacos antiepiléticos. É importante 
compreender os mecanismos moleculares subjacentes à doença, de modo a encontrar novas estratégias 
para combatê-la. 
Estudos no modelo da pilocarpina em rato indicaram que a hiperexcitabilidade na TLE 
experimental está associada a plasticidade sináptica anómala, através de alterações moleculares que 
consequentemente afetam a excitabilidade neuronal.  
A plasticidade sináptica é a capacidade que as sinapses apresentam de reforçar ou atenuar o seu 
rendimento em resposta a variações transientes na sua actividade que resultam de estímulos fisiológicos. 
A nível molecular, este mecanismo é caracterizado por alterações bidirecionais no número e actividade 
de alguns receptores de neurotransmissores e canais. Na potenciação de longo prazo (do inglês, LTP), o 
tipo de plasticidade sináptica mais estudado e conhecido no hipocampo, algumas destas alterações 
incluem o aumento dos receptores de ácido α-amino-3-hidroxi-5-metil-4-isoxazolo propiónico (Rs 
AMPA) no neurónio pós-sináptico, que aumenta a eficiência da comunicação glutamatérgica, e 
diminuição da corrente K+ do tipo A (IA), mediada por canais de potássio dependentes de voltagem 4.2 
(Kv4.2), que reduz a excitabilidade dendrítica.  
A modulação dos Rs AMPA pode afetar a excitabilidade neuronal através de alterações na 
estequiometria das subunidades e da fosforilação das mesmas. Estas alterações estão ambas implicadas 
na expressão da LTP no hipocampo assim como nas alterações patológicas em modelos de TLE em 
roedores. O aumento da excitabilidade neuronal está relacionado com a presença de Rs AMPA sem a 
subunidade GluA2, permeáveis ao ião Ca2+, e com a fosforilação da subunidade GluA1 na Ser831 e na 
Ser845, através do aumento dos Rs AMPA com maior condutância, na região sináptica. 
Alterações na expressão e modulação do canal Kv4.2 foram observadas tanto na LTP como na 
TLE. Sendo o principal mediador da corrente IA, a sua regulação afeta a excitabilidade dendrítica, que 
dela depende. Uma forma de modular o canal é através da fosforilação nos resíduos Thr602, Thr607 e 
Ser438. 
A densidade pós-sináptica (do inglês, PSD) tem um importante papel na regulação de cascatas de 
sinalização que ajustam a composição molecular das entidades pós-sinápticas necessárias para manter a 
plasticidade sináptica. Duas proteínas da PSD associadas à TLE são a proteínas pós-sináptica 95 (PSD-
95), que é expressa exclusivamente em sinapses glutamatérgicas (excitatórias), e a gefirina que se 
encontra exclusivamente em sinapses glicinergicas e GABAergicas (inibitórias).  
No sistema nervoso podem ser encontradas tanto jangadas lipídicas planares como caveolas, 
associadas às proteínas específicas, flotilinas e caveolinas, respectivamente. Estas jangadas são 
microdomínios membranares ordenados, ricos em colesterol e esfingolípidos e que estão associados a 
diferentes funções celulares. Estudos recentes sugerem que estes microdomínios podem estar envolvidos 
na plasticidade sináptica, fornecendo a estrutura necessária à organização e compartimentalização de 
diferentes eventos moleculares na neurotransmissão, tendo também um papel na sua regulação dinâmica 
de forma a aumentar ou diminuir a eficiência da comunicação sináptica. A remodelação da composição 
das jangadas lipídicas ocorre durante o desenvolvimento e contribui para alterações cognitivas e de 
plasticidade sináptica observadas durante o envelhecimento e doenças neurodegenerativas. No entanto, 
ainda não é claro se tais alterações contribuem para o declínio cognitivo e para as alterações na 
plasticidade sináptica encontradas na TLE.  
O principal objectivo deste trabalho foi avaliar as alterações nos marcadores da plasticidade 
sináptica e na composição sináptica de jangadas lipídicas num modelo de TLE induzida por lítio-
pilocarpina no rato, de forma a desvendar os mecanismos moleculares subjacentes à doença. 
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Num primeiro passo avaliaram-se por western-blot as alterações nos níveis e na fosforilação do 
canal Kv4.2 nos resíduos de Thr602, Thr607 e Ser438, relativamente à PSD-95 e à proteína pre-sináptica 
SNAP-25, em membranas de hipocampo obtidas de fatias nas quais se induziu LTP com um estímulo 
θ-burst moderado, que mimetiza a actividade neuronal fisiológica na região CA1 do hipocampo durante 
a aprendizagem e memória.  
Apesar dos níveis da proteína pós-sináptica, PSD-95 e da pré-sináptica, SNAP-25 não se alterarem 
em resposta à estimulação com θ-burst moderado, como era esperado, os níveis do canal Kv4.2 e da sua 
fosforilação nos resíduos de Ser438 e Thr602 aumentaram. Estes resultados sugerem um papel da regulação 
do canal Kv4.2 na LTP, através da fosforilação nos resíduos de Ser438 e Thr602. 
Para a caracterização do modelo de Li2+-pilocarpina no período crónico da TLE, foram primeiro 
realizados ensaios de histoquímica em fatias de hipocampo de ratos Wistar com 12 meses que exibiam 
convulsões espontâneas recorrentes (SRSs) induzidas pelo método do Li2+-pilocarpina e com controlos 
Sham. Nos ratos modelos da TLE de Li2+-pilocarpina, usando o marcador NeuN foi possível observar 
uma diminuição de neurónios na camada de células piramidais da região CA1 e CA3 e do hilus do giro 
dentado (DG). Foi vista também uma alteração de disposição dos neurónios da camada de células 
granulares do DG também observadas em resultados da coloração de Nissl. Por fim, com a coloração 
de Timm foi possível detetar sprouting axonal no DG nos ratos modelo da TLE, concordante com o 
observado em trabalhos anteriores. Neste estudo confirmamos então que o DG é a região do hipocampo 
que sofre maior dano neste modelo, o que é concordante com o observado no DG de pacientes com 
TLE.   
As alterações moleculares associadas à plasticidade sináptica foram avaliadas por western-blot em 
membranas de hipocampo obtidas de ratos modelo da TLE e Sham tendo como alvo: a subunidade 
GluA1 e GluA2 dos Rs AMPA, a fosforilação da subunidade GluA1 nos resíduos de Ser831 e na Ser845 
e a expressão do canal Kv4.2. Para avaliar alterações estruturais nas sinapses estudaram-se as proteínas 
da PSD, PSD-95 e gefirina e o marcador pré-sináptico SNAP-25. Por fim, estudou-se a expressão das 
proteínas específicas de jangadas lipídicas, flotilina-1 e caveolina-1.  
Os níveis de subunidade GluA1 e GluA2 diminuíram em ratos modelo da TLE, enquanto que a 
razão GluA1/GluA2 e a fosforilação da subunidade GluA1 na Ser831 e na Ser845 aumentaram. Estas 
alterações contribuem para um aumento da transmissão glutamatérgica que certamente contribui para o 
aumento da excitabilidade neuronal, e para a progressão da doença.  
Os níveis de SNAP-25 não se alteraram nos ratos modelo da TLE de Li2+-pilocarpina. Face aos 
níveis desta proteína a expressão relativa de PSD-95 diminuiu enquanto que a da gefirina aumentou. 
Uma vez que o PSD-95 e a gefirina são específicos para sinapses glutamatérgicas e 
GABAérgicas/glicinérgicas, respetivamente, estes resultados evidenciam que há mecanismos 
associados à transmissão glutamatérgica que estão diminuídos neste modelo enquanto que outros 
associados à transmissão GABAérgica/glicinérgica estão aumentados. Isto, por sua vez, sugere um 
aumento da transmissão inibitória e diminuição da excitatória, o que na totalidade diminui a 
excitabilidade neuronal. Esta alteração das proteínas da PSD poderá ser um mecanismo de adaptação 
molecular para contrariar a hiperexcitabilidade causada em parte pelas alterações descritas para os Rs 
AMPA, garantindo a sobrevivência do animal.  
A expressão do canal Kv4.2 não se alterou nos animais modelo da TLE, no entanto observa-se uma 
tendência para aumento e o estudo de um número mais elevado de animais poderá tornar mais clara esta 
questão. 
Finalmente, os níveis de flotilina-1 não se alteraram no modelo de TLE em rato enquanto que os 
níveis de caveolina-1 aumentaram, sugerindo que a caveolina-1 e alterações nas jangadas lipídicas têm 
um papel na fisiopatologia da TLE.  Face à sua ação noutros modelos de doença no SNC, este papel será 
provavelmente neuroprotector.  
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Para iniciar o estudo biofísico de jangadas lipídicas em membranas modelo preparadas com lípidos 
sinápticos do rato modelo da TLE de Li2+-pilocarpina, foram realizadas a deteção e quantificação 
biofísica de jangadas lipídicas em vesículas gigantes unilamelares preparadas com misturas de lípidos 
artificiais. A otimização da preparação de vesículas gigantes unilamelares por eletroformação foi 
efetuada com sucesso. 
Este trabalho revela alterações moleculares nunca descritas tanto para a LTP como para o período 
crónico da TLE no modelo de Li2+-pilocarpina em rato. No entanto, serão necessários estudos adicionais 
para melhor compreender o que é causa ou consequência da doença e, mais importante, o que pode ser 
feito para tratar ou prevenir a TLE. 
 
Palavras chave: Epilepsia do lobo temporal, Plasticidade sináptica, Jangadas lipídicas.  
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Epilepsy is one of the most common neurological diseases1, and is characterized by recurrent 
unpredictable seizures involving the synchronized firing of multiple neurons. It is associated with a 
chronic imbalance between excitatory and inhibitory transmission. Besides genetic changes, which 
make up a minor cause for the disease, epilepsy is believed to be a secondary consequence of brain 
insults such as acute seizures caused by toxic or febrile stimuli, stroke, head trauma, or cerebral 
infections2. According to the Epilepsy Foundation, approximately 60% of all living people with epilepsy 
have temporal lobe epilepsy (TLE), making it the most common form of focal epilepsy in humans3,4. 
Some of the changes found in patients with TLE include abnormal electroencephalograms (EEGs), 
memory impairment, hippocampal atrophy and sclerosis, as seen in Figure 1.1. At the cellular level 
changes include neuronal loss, gliosis and axonal sprouting, but also abnormal morphology. With the 
progression of the disease, alterations can spread to the rest of the brain, as seen in Figure 1.1 where 
besides the hippocampus, the whole right temporal cortex shows atrophy.  
  
 
Figure 1.1. Magnetic resonance imaging (MRI) brain scan from a patient with mesial TLE (MTLE). MTLE is associated 
with hippocampal atrophy and sclerosis, which includes neuronal loss and gliosis, but also loss of internal architecture. In this 
case an asymmetry of the brain is detected which is due to the temporal cortex atrophy.4 
 
Epilepsy is a major public health concern since 50 million people worldwide are epileptic1, and 
currently there are no disease-modifying therapies. Possible treatments include antiepileptic drugs, 
ketogenic diet, neurosurgical resection, and electrical stimulation of the nervous system5. In the 
particular case of TLE, about one third of the patients do not respond to therapy with antiepileptic drugs 
having to resort to hippocampal and/or amygdala resection surgery, from which 70% of the patients 
become seizure-free4. This drug resistance and the attempt to avoid cerebral surgery are the main reasons 
why it is imperative to explore the molecular mechanisms underlying TLE and find new strategies to 
fight it. 
Multiple experimental approaches have been developed to study TLE disease mechanisms. In vitro 
models usually consist of mammalian neuronal cell cultures or brain slices from animals, that are 
subjected to epileptic crisis (usually monitored using electrophysiological recordings), and can be 
acutely isolated or organotypic slices6. A wide range of species have been used to study epilepsy in an 
in vivo fashion, but the most common animals used to model TLE are the rodents Rattus norvegicus or 
Mus musculus (see ref 7 for review), due to their small size, rapid breeding and the possibility to use 
advanced genetic tools. Several procedures can be used to induce chronic seizures in these animals, such 
as: 1) electrical stimulation which includes the kindling model; 2) administration of chemoconvulsants 
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such as kainic acid (KA) or pilocarpine; and, less frequently, 3) brain hypoxia or ischaemia models. In 
addition, genetic models of seizure-prone rodents have been used. 
The properties of some antiepileptic drugs available today, e.g. phenobarbital, to which some 
patients are resistant, were found using simple acute seizure models5. One possible hypothesis is that 
the drug resistance found in epileptic patients is due to the fact that the acute models do not mimic the 
chronic state of the patients, characterized by spontaneous recurrent seizures (SRSs)5. Therefore, chronic 
models, also called SRS models are being used to better understand the disease and search for novel 
therapeutic approaches. 
In the lithium-pilocarpine (Li2+-Pilo) rat model of SRSs, pathological features including 
histological, behavioral, electroencephalographic (EEG) and pharmacological responses to antiepileptic 
and other drugs, resemble those observed in patients with MTLE, making it a good model of the human 
disease. The injection of pilocarpine induces an initial crisis of epileptic seizures or status epilepticus 
(SE), that lasts for up to a few hours. After typically 15 to 44 days with no observable seizures, a time 
called latent period, the animal starts to exhibit SRSs8,9. 
Abnormal synaptic plasticity has been found in animal models of epilepsy3,10,11 and in epileptic 
patients12, not only during epileptogenesis (the process by which the brain develops epilepsy13) but also 
in the chronic period of the disease. This altered plasticity relies on changes in α-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid receptors (AMPARs) and the voltage-gated potassium channels 4.2 
(Kv4.2 channel), among others.  
To better understand this association between disease and synaptic plasticity, it is important to first 
define synaptic plasticity itself. 
 
1.2. Synaptic plasticity 
 
Synaptic plasticity is a cellular process that confers synapses the ability to strengthen or weaken 
their communication in response to transient variations in their activity. These changes can endure for 
short or long periods and are considered crucial cellular mechanisms in learning and memory formation. 
Synaptic plasticity can involve changes at the molecular level, such as bidirectional scaling in the 
number and activity of some neurotransmitters receptors and channels14, or more profound structural 
cellular changes, like the formation of new synaptic contacts.  
In vitro, synaptic plasticity involves cellular changes in synaptic communication that can occur in 
a broad range of time frames and through different molecular processes depending on the stimulation 
pattern15–17. The two most studied forms of synaptic plasticity in the hippocampus are long-term 
potentiation (LTP) and long-term depression (LTD), since the lasting duration of the molecular and 
cellular changes observed suggests that these are crucial cellular mechanisms in hippocampal memory 
storage14.  
Using 2-amino-5-phosphonopentanoate, a competitive N-methyl-D-aspartate (NMDA) receptor 
antagonist, it was found that, LTP at hippocampal glutamatergic synapses is triggered by the activation 
of NMDA receptors18. The sustained depolarization of the postsynaptic membrane releases magnesium 
ions (Mg2+) that block NMDA receptors channels, allowing calcium ions (Ca2+)  to enter the cell (Figure 
1.2 - B)19. The influx of Ca2+ ions leads to autophosphorylation of enzyme Ca2+/calmodulin-dependent 
protein kinase II (CaMKII) causing its persistent activation15,20. This enzyme, in turn, catalyzes the 
phosphorylation of AMPARs21,22. 
The increase of intracellular Ca2+ and the consequent activation of CaMKII triggers the molecular 
events that drive synaptic plasticity (Figure 1.2) such as the recruitment of AMPARs to the synaptic 
region of the postsynaptic neuron, which then becomes easier to stimulate showing an increase in 
excitatory post-synaptic potentials (EPSPs)23. Simultaneously, there is an increase in dendritic 
excitability caused by the decrease of A-type K+ current (IA) mediated by Kv4.2 channel (see section 
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1.4)24. Other changes also include an increase in neurotransmitter release, an increase in postsynaptic 
ribosomes, changes in calcium compartmentalization, and growth of the actin cytoskeleton25,26. 
Other structural synaptic changes were found following LTP induction with θ-burst stimulation 
(TBS). The neck of dendritic spines (input neuronal protrusions) becomes wider and shorter, while the 
volume of the spine head increases, which facilitates protein traffic from dendrites into the spines, and 
enhances the synaptic contact area, leading to increased efficacy of synaptic transmission27. These spine 
changes are accompanied by modifications in the postsynaptic density (PSD)28. The PSD suffers a 
dynamic reorganization that modulates glutamate receptors (excitatory transmission) through linking 
these receptors to downstream signaling molecules that guarantee LTP expression29. 
 
 
Figure 1.2. Induction of LTP depends on NMDA receptors and AMPARs. In normal synaptic transmission (A), NMDA 
receptors have Mg2+ that blocks Ca2+ influx through the channel of this receptors. Sustained depolarization of the postsynaptic 
membrane (caused by high-frequency or TBS) drives Mg2+ out of the channel allowing Ca2+ influx (B), triggering synaptic 
changes such as the increase of AMPARs in the postsynaptic membrane (C).30 
 
Although many studies have focused on LTP, there is still a lot to uncover. One distinct problem is 
the fact that when this type of synaptic plasticity is being investigated the procedures followed, 
specifically stimulation that induces LTP, are not kept the same between studies, making it hard to learn 
how this mechanism is expressed and maintained physiologically.  
 
1.3. AMPA receptors 
 
AMPARs (Figure 1.3) mediate most of the excitatory glutamatergic neurotransmission across 
chemical synapses in the central nervous system (CNS), and changes in their activity, phosphorylation 
state, subcellular targeting and expression levels have been associated with physiological synaptic 




Figure 1.3. Overview of the AMPARs structure (A) and subunit composition (B). Each subunit contains four different 
hydrophobic domains (TM) that transverse the membrane. When the receptor is assembled with GluA2, the channel is not 
permeable to Ca2+, but without GluA2 the channel is permeable to Ca2+.31,32 
 
AMPARs are transmembrane homo or hetero-tetrameric ionotropic receptors assembled from four 
different subunits, GluA1-4 33 that share 68-74% amino acid sequence identity34. These differ in the C-
terminus where some post-translation modifications can occur, such as phosphorylation31. In the adult 
hippocampus, there are two major populations of AMPARs: those assembled with GluA1 and GluA2 
or those assembled with GluA3 and GluA2 subunits35. Only a small pool of AMPARs lack GluA2, being 
composed by GluA1 and GluA3 or solely by GluA1 subunits (homomeric receptors)35. 
Subunit stoichiometry is important in the modulation of gating kinetics, ion permeability and 
responsiveness to an array of small-molecule channel modulators36. When the receptor lacks the GluA2 
subunit, the core channel displays a strong, inwardly rectifying current-voltage relation as well as Ca2+ 
permeability, but not when GluA2 is present (Figure 1.3 - B)37,38. 
Knockdown of hippocampal GluA2 subunit promotes hyperexcitability, leading to a decrease in 
seizure threshold and seizure-like behavior39, thus increasing the risk of epileptogenesis40,41.    
AMPARs permeable to Ca2+ (lacking the GluA2 subunit), have been implicated in the expression 
of hippocampal LTP through protein kinase A (PKA)-dependent mechanisms42, which occur only when 
LTP is induced with strong and repeated TBS patterns. Following LTP induction a transient insertion of 
AMPARs without GluA2 in synapses, was observed42,43, suggesting that GluA2-lacking AMPARs 
might have a part in the expression of LTP. However, LTP can also occur without any detectable 
changes in AMPAR subunits stoichiometry44, which suggests that other mechanisms and changes might 
also play a role in mediating and consolidating LTP. 
After 85 days of SE induction with pilocarpine, mRNA levels of GluA2 are increased in the dentate 
gyrus (DG) of the rat hippocampus, but decreased in the CA1 area of the rat hippocampus45. An increase 
in the mRNA levels of GluA2 in the DG of the rat hippocampus was also detected, 2 weeks after SE 
induced with Li2+-Pilo46. 
Studies also relate GluA2 subunits-lacking AMPAR with TLE. One week after SE induction by 
Li2+-Pilo (latent period), three-week-old Wistar rats show no changes in the GluA1/GluA2 ratio in the 
hippocampus, but three days after SE the same ratio is increased in the medial prefrontal cortex (mPFC)3.  
 
1.3.1. Receptor phosphorylation 
 
Besides subunit stoichiometry, other mechanisms regulate AMPARs. GluA1 can undertake certain 
post-translation modifications such as phosphorylation in serine residues 818 (Ser818), 831 (Ser831) and 
845 (Ser845), which have been implicated in LTP expression. Also, GluA2 phosphorylation at serine 
residue 880 catalyzed by protein kinase C (PKC) has been associated with LTD, another synaptic 
5 
 
plasticity mechanism. For instance, the use of specific antibodies for phosphorylated GluA1 on Ser831 
or on Ser845, showed that both residues are phosphorylated when LTP is induced in the CA1 region of 
the hippocampus with four episodes of TBS, each consisting of ten trains delivered at 5Hz of four pulses 
at 100Hz47, a very strong stimulation paradigm.  
Our group studied GluA1 phosphorylation when the induction of LTP was carried using only one 
episode of TBS, each comprising only five trains of stimuli. Under these conditions, the phosphorylation 
of GluA1 subunits occurred only at Ser831 without changes in the GluA1 levels or phosphorylation at 
Ser845 (Figure 1.4)48. This difference is a consequence of the different stimulation paradigms applied and 
is consistent with the observations of Park et al., reporting that LTP induced by TBS is only PKA-
dependent when stronger and repeated TBS patterns are used49. Thus, only under these conditions 
phosphorylation at both Ser residues will happen, which suggests that these events are important in 
different phases of LTP: both Ser831 and Ser845 phosphorylation are required for late LTP, but only Ser831 
phosphorylation is associated with the initial phase of LTP.  
Ser831 phosphorylation can be catalyzed by PKC50 or by CaMKII21,22, an enzyme that, as mentioned 
before, has a role in LTP induction. This modification can lead to an increase of the time that AMPARs 
occupy the higher conductance states51, correlating to the increased conductance of synaptic AMPARs 
during LTP. This phosphorylation also drives AMPARs to the synaptic region52,53.  
 
 
Figure 1.4. GluA1 levels and phosphorylation following LTP induction with moderate TBS. Representative western-blots 
(B, D, F) and averaged changes observed in reactivity (A, C, E) in western-blots probing for GluA1 levels and phosphorylation 
on Ser845 and Ser831. Levels of GluA1 phosphorylated in Ser831 (C, D) were increased following LTP induction with TBS, but 
not total GluA1 levels or its phosphorylation on Ser845. CTR: control.   p -value < 0.001, Student's t-test 48. 
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Phosphorylation of Ser845 of GluA1 subunit is catalyzed by PKA50, which induces the insertion of 
AMPARs from the intracellular pool to the extra-synaptic region of the plasma membrane52,53. This 
modification also increases the open-probability of the receptor54.  
Phosphorylation at these two Ser residues has also been related to TLE pathology. Lopes et al 
showed that 50 days after SE was induced with pilocarpine (chronic period), levels of GluA1 
phosphorylated in Ser845 were reduced in the rat hippocampus, without any changes in GluA1 
phosphorylated in Ser831 or in GluA1 expression levels55. In another study, rats showing SRSs 60 days 
after SE induction with pilocarpine (chronic period) exhibited a decrease in GluA1 phosphorylation in 
Ser845 in the dorsal hippocampus, and a decrease of GluA1 phosphorylation in Ser831 in the ventral 
hippocampus8.  
 
1.4. Kv4.2 channel 
 
Across the neuron membrane, a variety of channels can be found, each contributing to different 
ionic currents. The largest and most diverse group of these ion channels is the potassium channel family, 
that has an important role in controlling neuronal excitability and plasticity56. As mentioned above, the 
IA current plays an important role in the enhancement of dendritic excitability associated with LTP. The 
main mediator of this current in hippocampal neurons is the Kv4.2 channel57.  
Kv4.2 belongs to the superfamily of potassium channels with six hydrophobic transmembrane 
domains (Figure 1.5)58 and is mostly expressed in the distal dendrites of neurons59,60. In response to a 
depolarization, the channel pore opens due to a conformational change triggered by the voltage sensor 
found in the fourth TM domain61.  
 Channel properties and function can be regulated by post-translational phosphorylation. There are 
a few highly conserved sites that can be phosphorylated by ERK (extracellular signal-regulated kinases) 
and other kinases of the MAPK (mitogen-activated protein kinases) family like the threonine 602 residue 
(Thr602) and threonine 607 (Thr607)62,63. When this happens, IA decreases, and internalization of the 
channel occurs63. ERK family can also catalyze the phosphorylation of Ser616, which suppresses the 
channel’s activity64.  
PKA also phosphorylates some sites in Kv4.2 channel, such as the threonine 38 residue (Thr38) or 
serine 552 residue (Ser552). The consequences of phosphorylation on Thr38 are unknown, but 
phosphorylation of Ser552 causes internalization of the channel65.  
Another possible phosphorylation site is Ser438, that can be phosphorylated by CaMKII, causing an 




Figure 1.5. Overview of Kv4.2 channel structure. The channel is composed of six TM domains, with an extracellular P-
domain between the fifth and the sixth. It also has three ERK phosphorylation sites (blue stars), Ser616, Thr607 and Thr602; two 
PKA phosphorylation sites (orange stars), Thr38 and Ser552; and one CaMKII phosphorylation site (red star), Ser438. CTD: 
carboxy-terminal domain; NTD: N-terminal domain. Adapted from 62. 
 
Induction of LTP reduces the levels of Kv4.2 on the membrane of dendrites (Figure 1.6 - B) which 
is accompanied by a shift in the voltage-dependence of IA. This suggests that control of the trafficking 
of the channel, which depends on modifications such as phosphorylation, could underlie a mechanism 
of LTP expression67,68.  
The first evidence that Kv channels could have a role in epilepsy came from the observation that 
Kv channel blockers induce convulsions in mice69. Studies in chronic TLE models have showed changes 
in Kv4.2 expression at several stages of disease progression. In animals with SRSs induced with 
pilocarpine, an increased excitability of neuronal pyramidal cell dendrites in hippocampal CA1 region 
was correlated with decreased dendritic availability of Kv4.2 channels and an increase in the 




Figure 1.6. Regulation of dendritic Kv4.2 channels by physiological activity and in epilepsy. Under control conditions (A) 
clathrin-mediated internalization, trafficking to the membrane and production of the Kv4.2 channel regulate the density of the 
channel in the dendritic membrane. The activity of the channel is also controlled by PKA, PKC, and MAPK dependent-
signaling. When LTP is induced (B) MAPK dependent-signaling activity and clathrin-mediated internalization are increased. 
Phosphorylation of the channel is also increased in SE of the pilocarpine model of epilepsy (C) but some of the mechanisms 
on the internalization of the channel are still unclear. In this situation, there is also a transcriptional downregulation of the 
channel.57 
 
In another study, in the Li2+-Pilo model of TLE, western-blot and immunohistochemistry studies 
have shown an increase in Kv4.2 expression that starts 6 hours after SE and continues to increase until 
2 days after the first grade of seizures (latent period). This is followed by a decrease in Kv4.2 expression 
during the chronic period (50 days after SE). These changes were more prominent in the CA1 and CA3 
regions of the hippocampus11. 
Besides the changes in phosphorylation and availability/trafficking of the channel on the 
membrane, a transcriptional down-regulation has also been reported in epilepsy (Figure 1.6 - C)70.  
 
1.5. Pre-synaptic protein: SNAP-25 
 
The synaptosomal-associated protein 25 (SNAP-25) is a component of the trans-SNARE (soluble 
n-ethylmaleimide-sensitive factor attachment protein receptor) complex, playing an important role at 
presynaptic vesicle fusion in neurotransmitter release71. Neurotransmitter release is regulated, amongst 
other mechanisms, by SNAP-25 palmitoylation. When SNAP-25 is palmitoylated, the protein partitions 
to the cell membrane allowing the SNARE complex to dissociate during vesicle fusion72. Palmitoylation 
is the post-translational modification in which a fatty acid palmitate (or less frequently other fatty acid) 
is attached covalently to a protein in a cysteine residue (and less frequently to serine and threonine)73.   
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A few observations relate SNAP-25 with synaptic plasticity but no changes have been reported in 
TLE. Increased mRNA levels of SNAP-25 were associated with the expression of LTP in the granule 
cells of the DG of the rat hippocampus74. Also, SNAP-25 is phosphorylated by PKC when LTP is 
induced with a high-frequency TBS75.   
 
1.6. Post-synaptic density proteins: PSD-95 and gephyrin 
 
The post-synaptic density (PSD; Figure 1.7) is a complex net of interacting proteins at the synapse 
that lies just underneath and in close connection with the post-synaptic membrane, opposed to the active 
zone of the presynaptic neuron. Its composition includes neurotransmitter receptors, effector proteins, 
enzymes, scaffold proteins and structural proteins29.  
 
 
Figure 1.7. The PSD, opposing presynaptic terminals forming glutamatergic synapses with two dendritic spines. The 
protein complex is visible with electron microscopy as a thickening of approximately 30 nm in the postsynaptic membrane (A). 
In (B) a tracing of the structures shown in (A), with its most important structures identified, is depicted 76. 
 
The molecules that compose the post-synaptic density have important roles, one of them being the 
regulation of downstream signaling pathways that adjust the molecular composition of the post-synaptic 
entities necessary to sustain synaptic plasticity77. 
An important protein found in these structures is post-synaptic density protein 95 (PSD-95), which 
is exclusively found in glutamatergic post-synaptic densities, associating with glutamate receptors and 
cytoskeletal elements78,79.  
PSD-95 has a role in synaptic stabilization and plasticity, through post-translational modifications 
such as phosphorylation and palmitoylation. PSD-95 palmitoylation on its N-terminus acts as an anchor 
for the protein in the postsynaptic membrane and is important for protein clustering at the PSD80,81. In 
fact, the PSD-95 palmitoylation cycle regulates AMPAR trafficking: high neuronal activity leads to 
PSD-95 depalmitoylation which induces its dissociation from PSD. Consequently, glutamate receptors 
are internalized and synaptic strength decreases. With lower neuronal activity, PSD-95 suffers 
palmitoylation promoting PSD-95 and glutamate receptors trafficking to the postsynaptic membrane80,82. 
Expression of PSD-95 lacking palmitoylation sites inhibits the incorporation of AMPARs into synapses 
during LTP83.  
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The hippocampus of rats with SRS-induced by KA, showed down-regulation of PSD-95 expression 
6 weeks post-SE, that correlates with a behavioral deficit. This decrease in PSD-95 expression, alongside 
other factors, likely contributes to behavioral impairments such as spatial learning memory deficit, 
anxiety and increased locomotor activity10. 
Like PSD-95 in excitatory synapses, gephyrin is found exclusively in inhibitory glycinergic and 
GABAergic synapses. This 93 kDa protein anchors glycine receptors and type A GABA (GABAA) 
receptors, to the cytoskeleton84–86, ensuring the stability that guarantees that the appropriate number of 
these receptors are localized at the post-synaptic membrane. Despite this stability, gephyrin scaffold 
sustains several forms of synaptic plasticity due to rapid changes in its composition77.  
Although not as well studied as PSD-95 regarding synaptic plasticity, gephyrin is believed to 
sustain it through the regulation of GABAA receptor internalization and function, i.e. by regulating the 
strength of GABAergic transmission. This regulation depends on changes in gephyrin through post-
translational modifications, such as phosphorylation and/or palmitoylation, and interaction with 
signaling molecules that modulate downstream signaling cascades related to synaptic plasticity in 
GABAergic synapses87.  
Patients with TLE showed aberrant alternative splicing in the gephyrin gene (GPHN), which lead 
to a gephyrin variant that clusters differently with GABAA receptors88. Also, a decrease in gephyrin 
expression was detected in the hippocampus of rats from 24 hours to 2 months after the first grade of 
seizures induced with Li2+-Pilo89. 
 
1.7. Summary of the changes found in TLE regarding the proteins mentioned 
 
Several studies have been conducted to study what molecular changes happen in TLE, both in 
human tissue and in rodent models of TLE. Some of the changes in proteins involved in synaptic 
plasticity studied in the present work, can be found in human tissue (Table 1.1). Changes in these 
proteins observed in different rodent models of TLE are summarized in Table 1.2. Results for human 
tissue are very similar to the ones obtained for rat models. Interestingly, for the rat models, the results 
not only vary between brain regions or even hippocampus areas, but also along different periods of the 
disease.   
 
Table 1.1. Protein changes found in patients with TLE. The diseased tissues were compared with non-seizure autopsies. 
Note that for some studies not all differences found in each study are described, only the ones that are relevant for the present 
work. ↑ represents an increase; ↓ represents a decrease. 
Author and 
year 
Situation Assay Details Result 
Blümcke et 
al. 1996 90 
Hippocampal tissue from patients with intractable 
TLE 
protein 
CA1 ↓ GluA2 




al. 1998 91 
Hippocampi from TLE patients (with and without 
hippocampal sclerosis) 
mRNA  ↑ GluA1/GluA2 
Palomero-
Gallagher et 
al. 2012 92 
Neocortical biopsies from patients with 
pharmacoresistant focal TLE 
protein  ↑ AMPAR 
Fang et al. 
2011 89 
Temporal neocortex samples from patients who 
underwent surgery to treat drug-refractory TLE 
protein  ↓ Gephyrin 
Ying et al. 
2004 93 
Brain tissue from four patients with medically 
intractable neocortical epilepsy 





Table 1.2. Protein changes found in rodent models of TLE. Note that for some studies not all differences found in each 
study are described, only the ones that are relevant for the present work. ↑ represents an increase; ↓ represents a decrease; - 








al. 1994 94 
Li2+-Pilo mRNA 
Hippocampus 
SE: 24 hours after 
treatment with pilocarpine 
↓ GluA1  
- GluA2 and GluA3 
Hippocampus 
DG 
SE: 12 hours after 





SE: 12-24 hours after 




al. 1998 45 
Pilocarpine mRNA 
Hippocampus 















et al. 2012 95 
Pilocarpine protein Hippocampus 
SE: 10 or 60 min after the 
first seizures 
↓GluA2 surface expression 




Latent period: 1 day after 




Latent period: 3 days after 
pilocarpine treatment 
↑GluA1 
1st to the 7th day after 
treatment with pilocarpine 
↓GluA2 
Latent period: 3rd day after 
treatment with pilocarpine 
↑GluA1/GluA2 
Lorgen et al. 
2017 96 
KA protein Hippocampus 8 weeks after SE ↓ GluA2 
Russo et al. 
2013 97 




















Chronic period: 50 days 
after SE 
- GluA1 and GluA1PSer831 





Chronic period: 60 days 






Su et al. 2008 
11 
Li2+-Pilo protein Hippocampus 
Latent period: 2 days after 
SE 
↑ Kv4.2 channel 
Chronic period: 50 days 
after SE 
↓ Kv4.2 channel 
Sun et al. 
2009 10 
KA protein Hippocampus 
Chronic period: 4 and 6 
weeks after SE 
↓ PSD-95 





from 24 hours to 2 months 






1.8. Lipid rafts 
 
Since the fluid mosaic model of membrane structure was proposed by Singer and Nicolson in 
197298, several new aspects of membrane organization have been uncovered (Figure 1.8), such as the 
transmembrane asymmetry of glycerophospholipids, but also the lateral heterogeneity (i.e., non-
randomness) in lipid and protein distribution (see 99 for review). In fact, the membrane is currently 
viewed as being composed by different functional domains which are distinct not only in their lipid and 
protein composition, but also in their biophysical properties, such as membrane lateral diffusion 
coefficient and thickness, and in the fact that they operate in a large range of time and length scales100.  
This lateral organization is highly relevant for the neuronal membrane due to all the roles associated 
to it, some of them already mentioned above, and especially, but not only, in synapses. The existence of 
lateral interactions between the high diversity of neural membrane components, with different degrees 
of affinity between them, drives and stabilizes the existence of different domains101. These domains are 
involved in the regulation of signaling pathways and other neurophysiological processes. Therefore, 
disturbance of this dynamic network in the membrane of neurons is associated with several pathologies, 
especially neurodegenerative diseases102. 
 
 
Figure 1.8. Schematic representation of the fluid mosaic membrane proposed by Singer and Nicolson modified to 
highlight the diversity of lipid components and their heterogeneous transversal and lateral distribution. Two types of 
domains are illustrated: those that are formed due to the segregation of different lipid components, and lipid annulus 
surrounding transmembrane proteins. Different colors correspond to different lipid species. The pink bulks represent proteins, 
and the black branches carbohydrates.103 
 
The term lipid raft was first used by Simons and Ikonen in 1997 to describe the existence of 
membrane domains that were more rigid (liquid-ordered; lo) formed by the dynamic aggregation of 
sphingolipids and cholesterol, that move along the liquid-disordered (ld) lipid bilayer, in a way similar 
to a raft on water104. Many studies have been conducted since then with the purpose of better 
understanding these domains. Regarding lipid raft composition in mammalian cells, it was found that 
besides cholesterol, these domains are also rich in a specific sphingolipid, sphingomyelin, and in 
glycosylphosphatidylinositol (GPI)-anchored proteins. From the Keystone Symposium on lipid rafts and 
cell function that happened in 2006 emerged the consensus definition of a membrane raft that is still 
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presently accepted. In addition to the already mentioned characteristics, this definition also includes the 
possibility of small rafts to be stabilized in order “to form larger platforms through protein-protein and 
protein-lipid interactions”105. The importance of these domains is evidenced by the functions that have 
been attributed to them so far, that include organization of signaling molecules for the assembly of 
signaling platforms or trafficking, and regulation of membrane fluidity.  
  
Figure 1.9. Lipids raft organization and possible roles in neurotransmitter signaling. Caveolae and planar lipid rafts (A) 
are two types of ordered microdomains found in the CNS. These domains are believed to spatially organize different membrane 
molecules to promote (B) or prevent (C) signal transduction106. 
 
In the CNS, lipid rafts have been associated with modulation of synaptic signaling by regulating 
neurotransmission and receptor trafficking107. The lipid raft signaling hypothesis proposes that these 
domains organize the spatial distribution of signaling molecules at the membrane in order to promote 
kinetically favorable interactions that are necessary for signal transduction (Figure 1.9 - B). The opposite 
might also happen, i.e. the inhibition of interactions by separation of the signaling molecules which 
results in a dampening of the signaling response (Figure 1.9 - C)106. Two different types of lipid rafts 
have been associated with these functions: planar lipid rafts and caveolae (Figure 1.9 - A)106. Caveolae 
are flask-shaped membrane invaginations that have caveolins as protein markers. In a similar way, 
flotillins are marker proteins found in planar lipid rafts. Both proteins are thought to promote stability 
of these domains. Localization within these microdomains affects the binding affinity of 
neurotransmitters to ionotropic receptors, such as AMPARs108–110. However, it is still unclear exactly 
how location within lipid rafts affects AMPAR properties.  
Palmitoylation is one of the mechanisms responsible for proteins recruitment to lipid rafts104. PSD-
95, along other proteins important for synaptic signaling, can be found in these domains in a 
palmitoylation-dependent fashion. During rat postnatal development an increase in PSD-95 
palmitoylation and lipid-raft constituent lipids were observed, which likely facilitate the formation of 
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lipid rafts81. In fact, remodeling of lipid raft composition in the CNS occurs during development and is 
believed to contribute to altered cognition and synaptic plasticity observed upon ageing and 
neurodegenerative diseases106,111. However, it is still unknown if such changes contribute to the cognitive 
decline and altered synaptic plasticity observed in TLE, and more studies are needed to better understand 
this issue.  
 
1.8.1. Membrane model systems 
 
The use of membrane model systems, such as Giant unilamellar vesicles (GUVs), is a good approach 
to study in detail a limited number of molecular interactions, to determine, amongst the overwhelming 
complexity surrounding biomembranes, which of those interactions are involved in a given biological 
process, and if they are altered in pathologies such as TLE. As stated above, cellular membranes can 
have different domains with different biophysical properties, such as fluidity. These properties vary 
according to the environment and composition of the membrane itself and are reminiscent of the lipid 
phases found in membrane model systems100. The existing lamellar phases, i.e., those in which the lipids 
are organized into a lipid bilayer, as in biomembranes, under close to physiological conditions are ld, lo 
and solid-ordered (so), here listed from more fluid to more ordered and compact112. It is usually 
considered that biological membrane domains, are in a fluid state, and therefore are considered either ld 
–like or lo –like domains, although evidence in the past decade has emerged for the existence also of so–
like domains in living cells under physiological conditions, at least in yeast113. Lipid phases and domains 
have been studied by a variety of spectroscopic and microscopic techniques112. One of those has been 
fluorescence spectroscopy and microscopy, which relies on the use of sensitive molecular probes  that 
have a certain preference in partitioning to specific domains, e.g. N-(lyssamine Rhodamine B sulfonyl)-
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (Rhod-DOPE) prefers to partition into ld  over lo and is 
largely excluded from so domains114.  
As membrane model systems, GUVs are liposomes with around 20 to 100 μm of diameter used to 
study, among others, how lipid composition affects shape and stability of domains. By using a 
fluorescent probe, domains with sizes on the μm range can be visualized by fluorescence microscopy, 
preferably using a laser-scanning confocal microscope115,116.  
From phase diagrams such as the one present in Figure 1.10, it is possible to estimate the percentage 
of each phase in the vesicle for each mixture, by using the tie-line which contains the proportion of 
components used in the experiment and the lever rule112. To obtain tie-lines in ternary systems usually 
it is necessary to physically separate the phases in coexistence and to determine the composition of each 
phase. To obtain the tie-lines in ternary lipid systems, namely from GUV imaging, information regarding 
the composition of each domain observed in the vesicles studied, especially the percentage of each 
component, would be needed117. This information can be indirectly estimated from spectroscopic 
measurements in which the spectra or quantitative parameters obtained can be separated in to the 
individual contribution of each phase, such as fluorescence lifetime components of fluorescent probes 
or Nuclear magnetic resonance (NMR), namely 2H-NMR of a lipid component with perdeuterated acyl 
chain versus 1H-NMR of the other lipid. Moreover, there are thermodynamic rules that restrict the 
different possible directions for the tie-lines. All together these theoretical and experimental approaches 
allowed to obtain ternary phase diagrams and several tie-lines, particularly in the ld/lo coexistence region 
with a high accuracy, with uncertainty in the order of 2 mol% or less. These phase diagrams are now a 
well-established and fundamental framework in membrane biophysical studies concerning membrane 




Figure 1.10. Miscibility phase diagram for DPPC, DOPC and cholesterol at 24°C.  Regions of different phase coexistence 
are defined by red boundaries as shown: the ld + lo, ld + so and lo + so areas indicate the respectively ld/lo, ld/so, lo/so phase 






The main objective of this work was to unravel molecular mechanisms underlying TLE which are 
yet to be discovered, regarding the role of lipid raft changes in abnormal synaptic plasticity observed in 
TLE.  
For this purpose, it is important first to understand what happens in physiological synaptic 
plasticity, namely LTP. Therefore, the first aim of this work was to study the changes in Kv4.2 channel 
phosphorylation in Ser438, Thr602 and Thr607, but also PSD-95 and SNAP-25, when LTP is induced with 
a moderate TBS.  
To understand the relation of altered lipid raft domains in TLE with abnormal synaptic plasticity, 
the hippocampus of Li2+-Pilo rat model of TLE was studied to evaluate: 
o Histological changes in hippocampal tissue regarding cell death and axonal sprouting; 
o Changes in the expression and phosphorylation of synaptic plasticity markers, AMPAR 
subunits GluA1 and GluA2, and Kv4.2 channel; 
o The changes in presynaptic and PSD markers, by studying the expression of PSD-95, 
gephyrin and SNAP-25; 
o And finally, the levels of flotillin-1 and caveolin-1. 
To initiate the biophysical study of lipid rafts in model membranes obtained from synaptic lipids 
from the Li2+-Pilo rat model of TLE the biophysical imaging and quantification of lipid rafts in giant 







All solutions were made using Milli-Q H2O (MilliQ® Gradient, Millipore) to reduce the possibility 
of contaminations.  
All reagents are from VWR, Merck or Fluka unless otherwise stated.  




The tissues available for this study were obtained from animal and in vitro studies performed at 
Instituto de Medicina Molecular and at the Rodent facility of the Faculty of Medicine of Lisbon (FML) 
where Li2+-Pilo treatment and brain dissection procedures were performed, as described below, by 
Doctor Diana Cunha-Reis or collaborators.  
Male Wistar rats were purchased from Harlan Iberica and were then kept under controlled 
environmental conditions (25°C, 50-60 % humidity, 12 hours light/dark cycle, light on at 6:00 hours) 
with free access to standard laboratory chow and tap water.  
All animal handling and experimental procedures were in accordance with standards established in 
the Guide for Care and Use of Laboratory Animals, Portuguese and European law on animal welfare 
and were approved by the Ethical Committee of FML. 
 
3.2. Brain dissection and hippocampus isolation 
 
Brain dissection procedures and isolation of the hippocampus were performed by D. Cunha-Reis 
under my careful observation in more than one occasion. Animals were killed by decapitation and the 
brain removed by exposing the cranium, cutting through the scalp of the rat with a scissors. Then the 
initial part of the spine that remained after the beheading, was removed, allowing the cut between the 
parietal and temporal bones, which were removed with the help of forceps, exposing the whole brain of 
the rat for removal. This was performed using a curved tip spatula, cutting the optical nerves, placing 
the brain in a Petri dish with a filter paper and submerging it in an ice-cold Krebs solution (10 mM 
C6H12O6.H2O, 124 mM NaCl, 26 mM NaHCO3, 3 mM KCl, 1.25 mM NaH2PO4.H2O, 2 mM CaCl2 e 1 
mM MgSO4) previously oxygenated with 5 % O2/ 5 % CO2. The two cerebral hemispheres were 
separated by the corpus callosum, using a blade under a magnifying glass (Olympus, Europe). The left 
and right hemisphere were then randomly assigned for fixation (see section 3.4.1 Histochemistry) or for 
hippocampal dissection. For histochemistry tissue samples were rinsed in oxigenated Krebs solution and 
then transferred to 10 % neutral buffered formalin. This later hemisphere was then placed with the inner 
face facing up, and a curved tip spatula was inserted in the lateral ventricular cleft between the 
hippocampus and the cortex, outlining it without disturbing the hippocampus. The cortical tissue was 
pushed and cut until it was possible to obtain a good hippocampus observation. With a microsurgery 
scissor the connection between the hippocampus and the septum was separated by cutting the tip from 
the fimbria that holds it. After that, using a spatula, the hippocampus was detached from its internal 
component, disconnecting it completely from the encephalus and all traces of cortical tissue removed. 
With the help of fine-tipped tweezers the visible blood vessels were removed to avoid homogenate 






3.3. Long-term potentiation studies 
3.3.1. Hippocampal slices preparation 
 
For electrophysiological recordings, hippocampal slices from 6-7 weeks-old rats were cut with a 
McIlwain tissue chopper from the isolated hippocampus. Slices (400 μm thick) were cut perpendicular 
to the long axis of the hippocampus and allowed to recover in a holding chamber for at least 1 h in 
gassed Krebs solution (10 mM C6H12O6.H2O, 124 mM NaCl, 26 mM NaHCO3, 3 mM KCl, 1.25 mM 
NaH2PO4.H2O, 2 mM CaCl2 e 1 mM MgSO4), at room temperature to allow the recovery of the damage 
made by the dissection procedure. 
 
3.3.2. LTP induction and electrophysiological recordings 
 
Hippocampal slices were introduced in an electrophysiology recording chamber previously perfused 
with Krebs solution and equilibrated at 30 °C. For the extracellular recording of the field excitatory post-
synaptic potentials (fEPSPs), the stimulation electrode was placed in the Schaffer collateral fibers of the 
CA1 region of the hippocampus and the recording electrode also in CA1 area but in the contact zone 
between the Schaffer collateral fibers and the dendrites of pyramidal cells as seen in Figure 3.1- A. Then, 
hippocampal slices were subjected to basal stimulation once every 15 s for at least 20 min or until a 
stable baseline was observed. After this, LTP was induced in (θ), but not in control (C), slices with a 
moderate TBS (one episode of five bursts of four pulses at 100 Hz with intervals of 200 ms (5x4); Figure 
3.1 - B) and the electrical activity of the slices monitored for 50 min under basal stimulation, after which 
slices were stored at -80 ºC until western-blot analysis. In each sample, 3-4 slices per condition were 
used. 
 
Figure 3.1. Schematic of the representation of the LTP induction procedure in rat hippocampal slices. The illustration 
shows the different hippocampal areas. (A) The stimulation electrode was placed in the Schaffer collateral fibers of the CA1 
region of the hippocampus and the recording electrode also in CA1 area in the contact zone between the Schaffer collateral 
fibers and the dendrites of pyramidal cells. (B) TBS consisted of five bursts of four 100 Hz pulses delivered with intervals of 




3.4. Lithium-Pilocarpine temporal lobe epilepsy rat model 
3.4.1. Lithium-Pilocarpine treatment 
 
Lithium chloride was injected at a dose of 100 mg/Kg, i. p., 24 hours prior to the administration of 
pilocarpine in 12-week-old rats. Furthermore, rats were pre-treated with α-methylscopolamine-bromide 
1 mg/Kg, 1h prior to pilocarpine treatment to counteract its peripheral cholinomimetic effects. 
Pilocarpine was injected in intervals of 30 min at an initial dose of 10 mg/Kg and 5mg/Kg 
reinforcements were given when necessary until acute SE was observed. Once SE was induced, the rats 
were treated with 4 mg/Kg of Xylazine, i. m., to prevent tonic-clonic muscle contractions. After 30 min 
of SE, rats received 10 mg/Kg of Diazepam, i.p., to terminate seizures. Reinforcements were 
administered to the animals that continued to preset seizures to ensure the survival of the animals. 
Animals were killed at 12 months of age (9 months after SE). A diagram representing all the steps 
performed is shown in Figure 3.2. 
 
 




Histochemistry and immunohistochemistry assays were performed by Pedro Pereira in Laboratório 
de Neuropatologia, Hospital Santa Maria, CHLN under my careful observation. 
Tissue samples were kept in 10 % neutral buffered formalin for up to 3 days. Then the samples 
were post-fixed in glutaraldehyde solution (3 % glutaraldehyde, 1.5 M dextrose) for 1.5 hours and then 
back to the 10 % neutral buffered formalin for 24 hours. For embedding in paraffin, the samples were 
then transferred to 70 % ethanol for a minimum of 4 hours up to days, and then placed in 95 % ethanol 
overnight. Then the tissue was switched to absolute ethanol 2 times for 2 hours each, and then to 
chloroform where it stayed overnight. Finally, the tissue was placed in wax for 4 hours at 60ºC and 
preserved until use  
The preserved tissue was cut in sections of 10-15 μm thick and placed in a water bath previously 
sprinkled with a small scoop of gelatin and chromium potassium sulfate, sparingly. The sections were 
mounted on positive slides which were then dried overnight in an incubator at 60ºC. Slides were finally 
dewaxed in xylene 2-3 times for 3 min each, and rehydrated in absolute ethanol, for 2 x 3min.  
For the NeuN-labelling antigen retrieval was performed by microwave heating in citrate buffer 
(10mM Tris-sodium citrate dihydrated, 0.05 % Tween 20, pH 6.0). pH was then equalized with PBS for 
5 min, and then the slices were incubated with the primary antibody for 1 hour. After being washed 2 
times with PBS the tissue was incubated with secondary antibody (Dako Envision) for 1 hour. The slides 
were then washed 2 times with PBS and rinsed in DAB for 5 min, followed by a counterstain in 
Harris/Mayer’s Hematoxylin. This was then washed 2 times with PBS and finally dehydrated with 
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absolute ethanol 2 x 3 min and mounted in Entellan. For NeuN-immunolabelling, neurons were counted 
using the Cell counter Plugin of ImageJ for each area of the hippocampus: CA1, CA3 and DG, whose 
region division was made as represented on Figure 3.1 - A.  
For the Nissl-staining, the sections were stained with 0.1% of Cresyl Violet Acetate 0.2% in acetate 
buffer, and then rinsed in tap water to remove excess stain. After washed with 70% ethanol, the staining 
was checked on microscope and if required the sections were immersed for 2 min in differentiation 
solution (2 drops of glacial acetic acid in 95 % ethanol). Finally, the tissue was dehydrated with absolute 
ethanol 2 x 3 min, cleared with xylene 2 times, and mounted in Entellan.  
In Timm-staining or Timm’s sulphide silver method, metals are transformed in a metal sulphide 
which then catalyses the reduction of silver ions by a reducing agent to metallic grains that are visible 
under a light or electron microscope119. So, the method is sensitive to metals, especially zinc, which 
makes it a good approach to visualize cells and detect newly sprouted axons and axon terminals in the 
tissue. For this staining the slides were stained with Timm stain (30 % Gum Arabic, 132 mM citric acid, 
90 mM sodium citrate, 155 mM hydroquinone, 5 mM silver nitrate) for 45 min in dark cupboard at room 
temperature, and then for 20 min at 60 ºC. The slides were then washed in de-ionized water and 
counterstained with cresyl violet working solution for 5min, followed by a dehydration with absolute 
ethanol 4 times for 1 min each. Cleaning the slides 3 times of 1 min each with xylene was followed by 
mounting in Cytoseal.  
 
3.4.3. Isolation of total hippocampal membranes for western-blotting 
 
Samples were homogenized in ice-cold sucrose-BSA-HEPES (320 mM sucrose, 1 mg/mL BSA, 10 
mM HEPES, 1 mM EDTA, pH 7.4) with protease (complete, mini, EDTA-free Protease Inhibitor 
Cocktail, Sigma) and phosphatase (1 mM PMSF, 2 mM Na3VO4, and 10 mM NaF) inhibitors using a 
Potter-Elvejam homogenizer (B.Braun Melsungen). The suspension was then centrifuged at 1000 g for 
10 min at 4 °C (eppendorf, MiniSpin). The supernatant was then collected and centrifuged at 14 000 g 
for 12 min at 4 °C (Eppendorf, centrifuge 5415D). The pellet was resuspended in aCSF (10 mM HEPES, 
1 mM MgCl2, 1.2 mM NaH2PO4, 120 mM NaCl, 2.7 mM KCl, 1.2 mM CaCl2, 10 mM glucose, pH 7.4) 
and centrifuged at 14 000 g for 2 min at 4 °C (Eppendorf, centrifuge 5415D). Finally, the resulting pellet 
was resuspended in aCSF and stored at -80 °C. 
 
3.4.4. Protein assays 
3.4.4.1. Determination of protein concentration 
 
The determination of the protein concentration was made following the Bradford method120 because 
of its quickness and accuracy. First the standard curve was stablished with the concentrations of 0, 0.1, 
0.2, 0.4, 0.7, 1.2 and 1.5 µg/mL of BSA diluted in Lysis buffer [45 mM Octylglucoside, 25 mM HEPES, 
150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 2 mM Na3VO4, 10 mM NaF, Protease inhibitors (complete, 
mini, EDTA-free Protease Inhibitor Cocktail, Sigma)]. The assays were performed in triplicate by 
adding 5 µL of the sample diluted 1:2 and 1:4 in Lysis buffer, and 245 µL of Bradford reagent 
(Coomassie Brilliant Blue G-250 0.1 g/L, Methanol 5 % (v/v), Orto-phosphoric acid 8.5 % (v/v)) to the 
wells of a microplate and left to incubate for 5 min. The absorbance was read in the spectrophotometer 
(TECAN, Sunrise; software: RdrOle4) at wavelength of 590 nm and 450 nm to calculate the ratio 
between the two.  






3.4.4.2. Protein quantification using Western-blot 
 
To identify and quantify specific proteins in each sample, western blot was performed (see 121 for 
review). The apparatus for gel preparation, electrophoresis and transfer steps were from BioRad. 
 
3.4.4.2.1. Gel preparation 
 
One small and one large (with integrated 1 mm spacers) glass plate, previously washed with Milli-
Q water and ethanol, were dried and put together, in a support with the according casting block. To 
detect leaks a bit of ethanol was poured between the plates and then removed. 10 % running gel mix [10 
% polyacrylamide, 375 mM Tris pH 8.8, 0.1 % SDS, 0.1 % APS, 0.1 %TEMED (this two were added 
last since they are the initiator peroxide and the catalyst respectively)] was then poured in between the 
glass plates (circa 5 mL); ethanol was placed on top of the polymerizing gel to prevent atmospheric 
oxygen from inhibiting polymerization. 
Once the running gel was polymerized, the ethanol was poured off and 5 % stacking gel mix (5 % 
polyacrylamide, 250 mM Tris pH 6.8, 0.1 % SDS, 0.1 % APS, 0.1 % TEMED) was poured on the top 
of the running gel, quickly placing a plastic comb over the gel avoiding the formation of air bubbles that 
would cause wells to be ill-formed.  
 
3.4.4.2.2. Sample preparation and loading 
 
Samples were mixed with 1:4 volume of sample buffer (4x Laemmli Sample Buffer, BioRad), and 
heated for 5 min at 100 °C (VWR, analog heatblock) to denaturate the proteins in the sample.  
The combs of the gel were carefully removed to prevent distortion of the wells. Gels were then 
placed in the holding block, which was placed in the electrophoresis tank. The space inside the block 
and the tank was filled with electrophoresis buffer (25 mM Tris, 192 mM Glycine, 0.1 % w/v SDS) 
making sure there was no leak and that all the wells were filled with the buffer and that no air bubbles 
remained in the wells.  
Once all the samples (15 µL per well), and 4-5 µL of pre-stained standards (Precision Plus Protein 
Standards, BioRad) were loaded in the respective wells, the power was set to 80 V and the 
electrophoresis was initiated. After allowing for the time necessary for the samples to reach the running 
gel, the voltage was switched to 135 V and left to run until the samples reached the bottom of the gel.  
 
3.4.4.2.3. Protein transfer to PVDF membranes and incubation with antibodies 
 
The running gel was removed from the glass plates very carefully and left to equilibrate in transfer 
buffer (25 mM Tris, 192 mM Glycine, 20 % w/v methanol) for at least 15 min. The same was made to 
PVDF membranes [Immobilon-P transfer membrane PVDF (pore size 0.45 µm), Immobilon] that were 
first activated in methanol. 
The transfer setting was then prepared by placing first the sandwich (black end down) following 
by a sponge, a filter, the gel, the membrane, again the filter and finally a sponge making sure that bubbles 
were removed using a roller at each step of stacking and that all the components enunciated were well 
moist with transfer buffer. The sandwich holder was then closed firmly and placed in a black/red holder 
inside the electrophoresis tank, filling the tank with a cold thermal bag (to make sure the high voltages 
don’t overheat the system) and transfer buffer. The tank is next placed inside a box filled with ice. The 
current was set to 370 mA and transfer of the proteins was performed for 2h. 
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Upon separation from the gel, PVDF membranes (now containing the proteins) were then briefly 
washed with Milli-Q water to remove any gel debris, and blocked with TBST (20 mM Tris, 150 mM 
NaCl, 0.1 % Tween 20) mixed with either 3 % BSA or 5 % milk for 2 hours at 4 °C with constant 
agitation in a rocking platform, VWR which will block nonspecific antibody binding sites. The 
membrane was then washed with TBST 3 times for 10-15 min with mixing (rocking platform, VWR) 
and incubated overnight with constant agitation at 4 °C with primary antibody prepared with the 
appropriate dilution in 3 % BSA in TBST and 0.02 % NaN3. 
On the next day membranes were washed 3 times with TBST for 10 min with mixing, and then left 
to incubate for 2 hours with mixing at 4 °C with secondary antibody prepared with the appropriate 
dilution in 3 % BSA in TBST. The primary and secondary antibodies used, and their according dilution 
is shown on Table 3.1. 
 
Table 3.1. Dilution of primary and secondary antibodies used and according blocking agent. 
Primary antibody Secondary antibody 
Target Source Brand Dilution 
Blocked 
with 












Millipore 1:500 BSA 1:5000 
GluA1 
PSer845 
Millipore 1:500 BSA 1:10000 








1:5000 BSA 1:10000 
Kv4.2 Millipore 1:1000 BSA 1:10000 
Caveolin-1 proteintech® 1:500 Milk 1:15000 



























































Membranes were then washed 3 times for 10 min with mixing with TBST followed by two 
immediate washes with Tris-buffer saline (20 mM Tris, 150 mM NaCl), and then prepared for revelation. 
For that the membrane is incubated with enhanced chemiluminescence mixture (HRP, Millipore) for 5 
min at room temperature and finally placed on the ImageQuantTM LAS 500 for revelation. Using ImageJ, 
the intensities of the signal for each protein target were obtained. The ratio of the signal from the 
different target proteins to the respective loading controls (GAPDH, Lamin-2B or β-actin) was used to 
normalize the signal intensities and correct for loading and sampling errors. All data are reported as 
percentage of Sham.  
Membranes were dried and stored at 4ºC between filter papers, wrapped in aluminum foil.  
 
3.4.4.3. Membrane stripping and re-probing 
 
Following detection of protein, membranes were often stripped of bound antibodies and re-probed 
with a different one. First the dry membranes were activated in methanol and then submerged in 
stripping buffer (62.5 mM Tris-HCl, 100 mM 2-mercaptoethanol, 2 % SDS) in a Petri dish for 30 min 
at 55 °C with occasional shaking. Then the membrane was washed with TBST and Milli-Q water 
alternatively for 10-20 min, until the 2-mercaptoethanol characteristic odor was gone. Then the Western-
blot steps were followed starting from the blocking of the membrane.  
 
3.4.5. Lipid assays 
 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC), cholesterol and N-(lyssamine Rhodamine B sulfonyl)-1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (Rhod-DOPE) were purchased from Avanti Polar Lipids, Inc.  
 
3.4.5.1. Lipid dosing 
 
Phospholipid quantification was made following the Rouser method122, a procedure in which 
released inorganic phosphate reacts with ammonium molybdate to form a complex with a strong blue 
color. The following volumes of Na2HPO4 0.5 mM were added to glass vials in triplicate for the 
calibration curve: 0, 20, 40, 80, 100, 140, 160 µL, and left to dry at 170 °C in a heat block (Techne, Dri-
block® DB3A). Separately, adequate volumes of the sample were added in triplicate to glass vials and 
dried under a nitrogen stream. Then, 300 µL of 70 % perchloric acid was added to all the vials at 170 
°C in the heat block for 45 min to digest the samples and release the inorganic phosphate. Once all were 
at room temperature, 1 mL of water, 400 µL of ammonium molybdate (1.25 %) and 400 µL of ascorbic 
acid (5 %) were added in this order to all the vials and mixed. Then, all were heated in a water bath 
(Bioblock scientific, polystat 33) for 5 min at 100 °C. After quickly cooling the vials with running water, 
the absorbance was read at 797 nm.  
 
3.4.5.2. Preparation of giant unilamellar vesicles 
 
GUVs were prepared by  electroformation as described by Angelova et al.123. Briefly, adequate 
volumes of lipids and probe (Rhod-DOPE) stock solutions were mixed to have a final lipid concentration 
of 1 mM, a lipid/probe ratio of 1:500 (mol/mol) and a chloroform/methanol ratio of 2:1 (v/v). Then, 25 
µL of this mixture previously homogenized by vortexing, was spread with a gas-tight syringe on the 
titanium GUV chamber. The traces of organic solvent were removed through vacuum desiccation for 
30 min. The titanium chambers were filled with 700 µL of sucrose solution 200 mM previously heated 
to 60 °C in a heat block (Techne, Dri-block® DB3A), sealed, connected to the signal generator and 
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placed in the block heater maintaining the system at 60 °C. A sinusoidal signal with a peak-to-peak 
voltage of 0.4 V and 10 Hz was applied and the voltage was increased to 2.0 V and maintained overnight. 
Then, the frequency was decreased to 4 Hz and the voltage increased to 2.6 V for 20 min Finally, the 
signal generator was turned off. The vesicle suspension was kept at room temperature (25 °C) in the 
dark until use. 
 
3.4.5.3. GUV visualization with confocal microscopy 
 
For GUV visualization 100 µL of each of the GUV suspension and 150 µL of glucose solution 200 
mM, were added to a chamber of an eight-well plastic plate with glass like coverslip bottom.  
Intensity images were taken using a Leica TCS SPE confocal microscope equipped with an X63 
(1.4 N.A.) oil-immersion objective. Rhod-DOPE was excited at 543 nm using the HeNe laser and its 
emission was detected in the range of 570-670 nm, which was adjusted directly using the equipment 
software taking advantage of the Acousto Optical Tunable Filter (AOTF). Images with a frame size of 
512 pixels x 512 pixels and 1024 x 1024 were acquired.  
 
3.4.5.3.1. 3D viewing and determination of the mole fraction of each domain in the GUVs 
 
The 3D projection of the GUVs was made by obtaining multiple images along different focal planes 
of the same sample (Z stacking), with an axial resolution (zz) of 0.344 μm, that was stacked together 
using FIJI software (3D Viewer), due to the optical sectioning capability of confocal microscopy. An 
approximate fraction area of each domain in 4 GUVs was estimated using the Measure area tool in 
ImageJ. 
 To estimate the fraction area of a spherical domain (lo) it was assumed that the GUVs are perfectly 
spherical and that the boundary between the domains is circular (Figure 3.3). Considering the scheme 
in Figure 3.3, the area of the dark domain (Adark) is given by the following equation: 
 
𝐴𝑑𝑎𝑟𝑘 = 2𝜋 . 𝑅 . 𝐵𝐶̅̅ ̅̅  
  Eq 3.1. 
 Since the OAC triangle is rectangle:  
𝐵𝐶̅̅ ̅̅ = 𝑅 − √𝑅2 − 𝐴𝐵̅̅ ̅̅ 2 
Eq 3.2. 
  Replacing BC̅̅̅̅   in the first equation results in:  
𝐴𝑑𝑎𝑟𝑘 =  2𝜋 . 𝑅 . (𝑅 − √𝑅
2 − 𝐴𝐵̅̅ ̅̅ 2) 





Figure 3.3. GUV representation for determination of domain area fraction. The right area is non-fluorescent representing 
a lo domain. 𝑂𝐴̅̅ ̅̅  and 𝑂𝐶̅̅ ̅̅  are the GUV radius (R), while 𝐴𝐵̅̅ ̅̅  is the semi-major axis of the circular boundary that separates the 
domains.124 
 
To calculate the percentage of each domain, for each GUV prepared with the ternary mixture, the 
AB̅̅ ̅̅  from the dark areas and the radius of 12 vesicles prepared with DPPC/DOPC/chol were found and 
used in equation 3.3. If one GUV had more than one of these areas, then after estimating the area for all, 
these were summed up. 
To determine the mole fraction associated to each area fraction estimated the expressions from 
Marquês et al. supplementary material125 were used. If x and y are two different and coexisting domains 




 Eq 3.4. 
in which Nx expresses the total number of molecules in the x phase and Nt the total number of molecules 
in the GUV.  
Considering the following definitions: 
𝑎𝑥 =  
𝐴𝑥
𝑁𝑥










where ax is the area per lipid, Ax stands for the total area x occupies, while At is the total superficial area 



































 Eq 3.9 




𝑓𝑥  𝑎𝑦 
𝑓𝑦 𝑎𝑥 − 𝑓𝑥  𝑎𝑦 
 
Eq 3.10 
To perform these calculations, it was considered that for the DPPC/DOPC mixture ald = 65 Å and 




Statistical analysis was performed using GraphPad Prism 6 software. All results were expressed as 
mean ± standard error of the mean (SEM). Since data had normal distribution, parametric statistic 
method Student’s t-test was applied to compare two samples. The differences were considered as 






4.1.  Long-term potentiation by θ-burst stimulation in vitro 
 
LTP was induced with a moderate TBS in hippocampal rat slices. Extracellular electrophysiological 
recordings and the time-course of these experiments are shown in Figure 4.1. - A. After 1 hour of 
stimulation the slope of the field excitatory post synaptic potentials (fEPSPs) increased by 27.4 ± 3.8 % 
(n = 6; Figure 4.1. - B).  
 
Figure 4.1. LTP induced by moderate TBS. (A) Extracellular electrophysiological recordings of fEPSPs (inset) and time-
course of the slope of fEPSPs in the hippocampus, before (1), during and until 1 hour after (2) of LTP induction. (B) 
Enhancement in fEPSPs slope observed 1 hour after TBS. Values are the mean  SEM of 6 experiments (n = 6; 6 hippocampal 
slices). *p-value < 0.5; Student’s t-test.  
 
Hippocampal membranes obtained from θ-burst stimulated (θ) and control (C) slices were used to 
evaluate Kv4.2 channel phosphorylation, PSD-95 and SNAP-25 levels by western-blot.  
 
4.1.1. Kv4.2 channel phosphorylation following LTP induction 
 
As previously mentioned, the activity and presence of Kv4.2 channel in the membrane is changed 
in LTP. However, it is still unclear if the modulation of the channel through phosphorylation is able to 
change its activity and/or play any role in LTP caused by moderate TBS. To investigate if the levels of 
phosphorylated Kv4.2 channel change following LTP induction with TBS, the western-blot technique 
was used. 
In Figure 4.2 the raw data for the Kv4.2 channel phosphorylation experiments are depicted. Due to 
the limited amount of tissue available for these experiments, and to the low levels of phosphorylated 
channels under control and test conditions, it was not possible to obtain a reliable band intensity for 
band densitometry analysis for the Kv4.2 channel phosphorylated in Thr607 and some of the results could 
not be used. Quantification of the changes in channel phosphorylation in Thr602 was not possible since 
the majority of the control samples did not show any staining, although stimulated samples did show it 





Figure 4.2. LTP induction with moderate TBS enhanced the levels of Kv4.2 channels and its phosphorylation on Ser438, 
but not on Thr602 and Thr607. Average % change in band density (top) and representative western-blots (bottom) of the 
observed changes in the different forms of Kv4.2 and loading control. Experiments were performed in total hippocampal 
membranes isolated from stimulated (θ) and control (C) slices as described in Methods. Kv4.2 channel levels and its 
phosphorylation in Ser438, Thr602 and Thr607 were probed with antibodies specific for this protein or its phosphorylated forms. 
Values are the mean  SEM of 3 to 4 experiments (each n represents one animal, 3-4 slices per animal ). *p-value < 0.05, 
****p-value < 0.0001; Student’s t-test.  
 
The levels of Kv4.2 channel increased by 27.9 ± 8.6 % (n = 4) following LTP induction (Figure 
4.2 – Kv4.2). As for the phosphorylation of the Kv4.2 channel, there were no changes in phosphorylation 
in Thr607 between control samples with  θ-burst stimulated ones (Figure 4.2 – Kv4.2PThr607). But, Kv4.2 
channel phosphorylation in Ser438 increased significantly by 85.6 ± 7.6 % in θ samples (Figure 4.2 – 
Kv4.2PSer438).  
Although quantitative analysis for the Kv4.2 channel phosphorylated in Thr602 was not possible, a 
qualitative analysis was made. Most of the control samples did not show any staining, i.e. there is no 
Kv4.2 phosphorylation in Thr602 in the control samples. However, for samples stimulated with TBS 
Kv4.2 channel phosphorylation in Thr602 was detected in all samples as evidenced by the presence of a 
very low intensity band in the respective western-blot results.  
It is also important to express results for the phosphorylated forms as the percentage variation ratio 
to the change in Kv4.2 channel levels, to quantify the modification in Ser438 without the contribution of 
the increase found for the total amount of the channel found in θ-burst stimulated samples.  
When corrected for the enhancement in Kv4.2 levels, the changes in Kv4.2 phosphorylation were 
qualitatively similar to the ones described above. The phosphorylation of the channel in Thr607 did not 





Figure 4.3. LTP induction with moderate TBS enhanced the percentage variation ratio to Kv4.2 channel of 
phosphorylation on Ser438, but not on Thr607. Average % change in the ratio of the different phosphorylated forms of Kv4.2 
to the channel itself. Values are the mean  SEM of 3 experiments (each n represents one animal, 3 slices per animal). **** p-
value < 0.0001; Student’s t-test. 
 
4.1.2. PSD-95 and SNAP-25 levels following LTP induction 
 
To make sure that there were no major structural changes at the synapse following LTP induction, 
the changes in the levels of two synaptic proteins were studied upon TBS: SNAP-25, a pre-synaptic 
protein, and PSD-95, a post-synaptic protein. As shown in Figure 4.4, the levels of these two proteins 
did not change. 
 
Figure 4.4. LTP induction with moderate TBS did not change PSD-95 and SNAP-25 expression. Average % change in 
band density (top) and representative western-blots (bottom) of the observed changes in PSD-95 and SNAP-25 levels. 
Experiments were performed in total hippocampal membranes isolated from stimulated (θ) and control (C) slices as described 






4.2.  Lithium-pilocarpine model of TLE 
 
To understand the changes in lo domains in the rat model of SRSs resembling human MTLE, a 
validation of the changes in neuronal survival and hippocampus organization, gliosis, synaptic proteins 
and synaptic plasticity associated channels was performed, that would allow lipid changes to be put in 
context. Results in chronic SRS rats (Epi) are compared with the ones obtained in rats used as control 
(Sham), which undergone the same procedures and have received the same treatment and drugs as the 
Epi rats except for the disease inductor, pilocarpine, that was replaced with a vehicle injection. 
An interesting note is that the volume of the hippocampus of Epi rats was smaller than Sham and 
had more white nerve fibers on the Alveus surface.  
 
4.2.1. Neuronal survival and hippocampus organization 
 
The extent of neuronal survival and changes in hippocampal architecture in the Li2+-Pilo rat model 
were evaluated by immunohistochemistry against neuronal nuclear protein (NeuN)-labelling and by 
Nissl- and Timm-staining (n = 3).  
Overall, cerebral structures of Epi rats were not as well defined as for Sham rats, being harder to 
obtain a clear image of the hippocampus without artefacts from the fixation for the former group. In 
some cases, part of the hippocampus was missing. This was probably due to hippocampal atrophy that 
caused a greater detachment of the hippocampus of Epi rats from the surrounding cerebral tissue, making 
it very flexible and more sensible to the cutting and fixation process. 
 
4.2.1.1. NeuN immunolabelling 
 
NeuN – neuronal nuclear protein – a specific neuronal marker, was used to investigate the general 
cellular organization of the hippocampal layers and areas of Epi rats, as compared to Sham. 
For all the Sham rats, the three main areas of the hippocampus, CA1, CA3 and DG, had the expected 
appearance of and healthy hippocampus (Figure 4.5 – Sham). However, the same was not observed for 
all the three Epi rats, although large differences were noticed between the three individuals. These 
differences in Epi rats can be due to differences between seizures frequency and total number as well as 
time passed since chronic seizure onset. Noticeably, one of the rats started to have seizures earlier than 
the other two. 
In Epi rats, more neurons are detected in the stratum radiatum and stratum lacunosum-moleculare 
than in Sham rats (Figure 4.5 – A vs D), also the pyramidal cell layer of the CA1 region was thinner 
than the same layer in Sham rats. The pyramidal cell layer of the CA3 region of Epi rats had less neurons 
than Sham rats (Figure 4.5 – B vs E). Finally, the DG granular cell layer did not have a uniform thickness 
along the layer and had a different architecture in Epi rats (Figure 4.5 – C vs F). Also, the DG granular 





Figure 4.5. Loss and dispersion of CA1 and CA3 pyramidal cells in the hippocampus of Epi rats. Representative 
immunohistochemistry images of NeuN+ cells in Sham (A-C) and Epi rats (D-F) in the hippocampal CA1 (A, D), CA3 (B, E) 
and DG (C, F) regions. Brain samples were subjected to formalin fixation and paraffin embedding. Scale bars represent 50 μm. 
 
A neuron count for each hippocampal region was performed for all animals (Figure 4.6). In CA1 
and CA3 hippocampal region no significant differences were observed between Epi and Sham rats, due 
to the fact histological differences were inconsistent between Epi rats. However, in the DG, histological 
differences were more consistent, and Epi rats showed on average 24.5 ± 6.4 % (n = 3) fewer neurons 
than Sham. 
 
Figure 4.6. Epi rats have less neurons in the DG than Sham rats. Change in the number of neurons in the CA1, CA3 and 
DG regions of the hippocampus for Epi and Sham rats. Values are the mean  SEM of 3 experiments (n represents the number 




Nissl staining is a selective method for detecting Nissl bodies - large granules of endoplasmic 





Figure 4.7. Loss of CA1 pyramidal cells in the hippocampus of Epi rats. Representative images of Nissl-stained cells in 
Sham (A-C) and Epi rats (D-F) in the hippocampal CA1 (A, D), CA3 (B, E) and DG (C, F) regions. Brain samples were 
subjected to formalin fixation and paraffin embedding. Scale bars represent 50 μm. 
 
Results for Nissl-staining show that in all Epi rats the CA1 pyramidal cell layer is narrower than in 
Sham (Figure 4.7 - Sham), but neuron scattering is not obvious from this coloration as it is with NeuN-
labelling. The CA3 area of Epi rats is very similar to the one of Sham rats (Figure 4.7 – B and E). Epi 
rats have a different architecture of the DG as described for the NeuN labelling results: the granular cell 
layer has variations in the thickness and its shape is more angular. However, differences in neuron 




Timm-staining revealed a denser staining in the principal cell layers, especially in the granular cell 
layer of the DG and more fainted in the pyramidal cell’s layers of CA1 and CA3 (Figure 4.8). In the 
stratum radiatum of the CA1 region of Epi rats, an enhancement in the number of axons is detected, 






Figure 4.8. Axon sprouting in the hippocampus of Epi rats. Representative images of Timm-stained cells in Sham (A-C) 
and Epi rats (D-F) in the hippocampal CA1 (A, D), CA3 (B, E) and DG (C, F) regions. Brain samples were subjected to 
formalin fixation and paraffin embedding. Scale bars represent 100 μm. 
 
4.2.2. Proteins involved in synaptic plasticity and in lipid raft structure 
 
Changes in synaptic plasticity in SRSs rats (TLE model) were evaluated by western blot in isolated 
hippocampal membranes of Sham and Epi rats. Samples were probed for different target proteins and 
their post-translational modifications: AMPAR subunits GluA1 and GluA2, (and GluA1 
phosphorylation in Ser831 and in Ser845), PSD-95 and gephyrin, SNAP-25, Kv4.2 channel, and flotillin-
1 and caveolin-1.  
 
4.2.2.1. AMPA receptor subunits GluA1 and GluA2 
 
Changes in AMPARs levels, phosphorylation and activity have been described in association with 
human TLE and in animal models of the disease, affecting its permeability to Ca2+ ions. The levels of 
GluA1 and GluA2 subunits were first evaluated, to determine GluA1/GluA2 ratio which reveals changes 
in the receptor subunit stoichiometry.  
GluA1 and GluA2 levels were lower in Epi rats when compared to Sham. GluA1 levels decreased 
by 42.8 ± 17.5 (n = 4) and GluA2 levels by 50.2 ± 6.8 % (n = 3) respectively (Figure 4.9). The 





Figure 4.9. Epi rats have lower levels of GluA1 and GluA2 but higher GluA1/GluA2 ratio then Sham rats. % change in 
band density (top) and representative western-blots (bottom) of the observed changes in GluA1 and GluA2 subunit and 
respective ratio. Experiments were performed in total hippocampal membranes isolated from Epi and Sham rats, as described 
in Methods. GluA1 and GluA2 levels were probed with antibodies specific for each of these proteins. Values are the mean  
SEM of 3 to 4 experiments (n represents the number of animals). *p-value < 0.05, **p-value < 0.01; Student’s t-test.  
 
4.2.2.2. AMPA receptor subunit GluA1 phosphorylation 
 
AMPAR activity is not only modulated by stoichiometry, but also by phosphorylation of its 
component subunits. Phosphorylation of GluA1 AMPAR subunit is of particular relevance in synaptic 
plasticity. By performing western-blot studies using phospho-specific antibodies the phosphorylation of 




Figure 4.10. GluA1 phosphorylation in Ser831 and in Ser845 did not change between Sham and Epi rats. Average % change 
in band density (top) and representative western-blots (bottom) of the observed changes in GluA1 phosphorylation in Ser831 
and Ser845. Experiments were performed in total hippocampal membranes isolated from Epi and Sham rats, as described in 
Methods. GluA1 phosphorylated in Ser831 and Ser845 levels were probed with antibodies specific for each of these two forms. 
Values are the mean  SEM of 4 experiments (n represents the number of rats). Student’s t-test did not reveal significant 
differences.  
 
The levels of phosphorylated GluA1 subunit were not different between Sham and Epi rats (Figure 
4.10) which could indicate that these modifications have no relevance in TLE. However, it is important 
to correct the results for phosphorylation of GluA1 to the variation of GluA1 levels between Epi and 
Sham rats, that also contributes to changes in band density. When this is considered (Figure 4.11), 
phosphorylation of GluA1 on both Ser831 and Ser845 is increased by 63.5 ± 19.8 (n = 4) and 59.9 ± 16.4 
% (n = 4), respectively.  
 
Figure 4.11. Epi rats have higher levels of GluA1 phosphorylated in Ser831 and in Ser845 when total amount of GluA1 
subunit is considered. Average % change in the ratio of both phosphorylated forms of GluA1 subunit, Ser831 and Ser845, with 




4.2.2.3. Pre and post-synaptic markers 
 
Other targets studied with western-blot were PSD-95 and gephyrin, two proteins that are 
specifically located at the glutamatergic and the GABAergic PSD, respectively. Besides these two 
proteins, pre-synaptic protein SNAP-25 levels were also studied. Although SNAP-25 levels did not 
change in Epi rats when compared with Sham, PSD-95 levels decreased in Epi rats by 53.5 ± 13.9 % (n 
= 4)  while gephyrin levels increased by 24.4 ± 5.2 % (n = 3; Figure 4.12).  
  
Figure 4.12. PSD-95 levels in Epi rats is lower than in Sham rats, and gephyrin levels are increased in Epi rats, while 
SNAP-25 levels are not changed. Average % change in band density (top) and representative western-blots (bottom) of the 
observed changes in PSD-95, gephyrin and SNAP-25. Experiments were performed in total hippocampal membranes isolated 
from Epi and Sham rats as described in Methods. PSD-95, gephyrin and SNAP-25 levels were probed with antibodies specific 
for each of these proteins. Values are the mean  SEM of 3 or 4 experiments (n represents the number of rats). **p-value < 
0.01; Student’s t-test.  
 
To evaluate how post-synaptic changes relate to the pre-synaptic proteins in Epi rats, the ratio 
between the post-synaptic proteins, PSD-95 and gephyrin, with SNAP-25 was calculated (Figure 4.13 
– PSD-95/SNAP-25 and gephyrin/SNAP-25). The percentage variation ratio of PSD-95 to SNAP-25 
revealed a decrease of 48.8 ± 14.5 % (n = 4) relative to the presynaptic marker while gephyrin increased 





Figure 4.13. The ratio of PSD-95 and gephyrin with SNAP-25 decreased and increased respectively in Epi rats when 
compared with Sham rats. Average % change in the ratio of PSD-95 and gephyrin with SNAP-25. Values are the mean  
SEM of 3 or 4 experiments (n represents the number of rats). *p-value < 0.5; Student’s t-test.  
 
4.2.2.4. Kv4.2 channel 
 
As with LTP evoked by TBS (chapter 4.1.1.), the influence of SRSs on Kv4.2 channel expression 
was also studied by western-blot. Although it would have been interesting to study also the 
phosphorylation as previous studies have shown these modifications in TLE rodent models, this was not 
considered crucial for the characterization of our model.  
The expression levels of the channel, were not significantly changed in Epi rats (Figure 4.14), but 
increasing the number of animals may be required.  
 
Figure 4.14. Kv4.2 channel levels did not change between Epi and Sham rats. Average % change in band density (top) and 
representative western-blots (bottom) of the observed changes in Kv4.2 channel. Experiments were performed in total 
hippocampal membranes isolated from Epi and Sham rats as described in Methods. Kv4.2 channel was probed with a Kv4.2 






4.2.2.5. Lipid rafts proteins: flotillin-1 and caveolin-1 
 
Finally, the levels of lipid rafts stabilization proteins flotillin-1 and caveolin-1 levels were also 
investigated, to find out if these microdomains suffer alterations in TLE. When the level of these proteins 
increases, it is expected that there is also an increase in the abundance of the membrane domains in 
which each one is preferentially localized. 
The results in Figure 4.15 show that, although flotillin-1 levels did not change between samples, 
caveolin-1 levels increased by 57.2 ± 9.0 % (n = 3) in Epi rats.  
 
Figure 4.15. Flotillin-1 levels did not change, and caveolin-1 levels are increased in Epi rats when compared with Sham 
rats. Average % change in band density (top) and representative western-blots (bottom) of the observed changes in flotillin-1 
and caveolin-1. Experiments were performed in total hippocampal membranes isolated from Epi and Sham rats as described in 
Methods. Flotillin-1 and caveolin-1 levels were probed with antibodies specific for each of these proteins. Values are the mean 
 SEM of 3 experiments (n represents the number of rats). **p-value < 0.01; Student’s t-test.  
 
4.3. Imaging and quantification of lipid domains in GUVs 
 
In the present study, analysis of GUVs prepared with lipids extracted from Epi and Sham rat 
synaptosomes would be important to know if there are any differences between these two samples at 
synapses, regarding lipid rafts presence and stability. However, the number of biological samples was 
scarce and limited, and from each synaptosomes preparation only a small amount of lipid could be 
extracted. Therefore, before working in Epi and Sham samples, it was imperative that all the 
methodologies and techniques inherent to the preparation, imaging and analysis of the domains of GUVs 
with complex composition were well optimized, to avoid any possible waste of sample. So, optimization 
of all the procedure and equipment was made by preparing GUVs by electroformation with binary and 
ternary mixtures of highly pure synthetic lipids which phase behaviour is well known and there are no 
limitations regarding sample quantity. Optimization of the preparation procedure took longer than 
39 
 
initially anticipated. So, the results presented here are only the ones obtained for the optimization of the 
procedure.  
For that purpose, two lipid mixtures labelled with Rhod-DOPE were prepared with equimolar 
proportions of the lipid components: DPPC/DOPC and DPPC/DOPC/cholesterol (chol).  
Since Rhod-DOPE was used as a membrane probe, all the GUV regions with stronger fluorescence 
correspond to the presence of ld domains. Any weakly or non-fluorescent zones that appear in the 
membrane could be any of the other domains, i.e., ordered domains. Lo domains have a spherical shape 
and there are usually more than one, while so usually have a thread disformed-like appearance.   
 Looking at the miscibility phase diagrams (Figure 1.10) of the mixtures used in this work at room 
temperature only two phases for each mixture are expected: for the binary ld-so and for the ternary ld-lo.   
For the lipid systems used in this work, previous studies of these systems allowed to draw the 
respective tie-lines, and by using these it is possible to have an estimate of the molar percentage expected 
for each type of domain (Table 4.1- Lit).  
For the binary mixture of DPPC/DOPC (Figure 4.16) the GUVs obtained were small with around 
10-15 μm in diameter. However, after careful observation of each one it was possible to notice non-




Figure 4.16. Confocal microscopy of GUVs prepared with DPPC/DOPC (equimolar) and Rhod-DOPE as a fluorescent 
probe reveals the coexistence of so and ld phases. (A, B) Two different planes of the same preparation, where several GUVs 
with so domains are identified with white arrows. (C, D) A GUV with around 10 μm in diameter, observed in two different 
focal planes and its three-dimensional representation obtained through a 3D projection of confocal sections (E). The non-
fluorescent zones pointed by white arrows represent non-ld domains, that have a snake-like shape which means it corresponds 






Figure 4.17. Confocal microscopy of GUVs prepared with DPPC/DOPC/chol (equimolar) and Rhod-DOPE as a 
fluorescent probe reveals the presence of ld and lo, i.e., raft-like domains. (A, B) Two different planes of the same 
preparation and its three-dimensional representation obtained through a 3D projection of confocal sections in black (C) and 
white (D) background. (E, F) Two selected GUVs in two different planes and their three-dimensional representation obtained 
through a 3D projection of confocal sections (G, H). The non-fluorescent zones pointed by white arrows represent non-ld 




As for the ternary mixture which has the same components as the binary and, in addition, 
cholesterol, all in equimolar amounts, it was easier to obtain bigger GUVs in larger number (Figure 4.17 
– A and B) than for the binary mixture. Each GUV had around 20 μm in diameter with the biggest one 
having more than 30 μm. Zooming in, the presence of round shaped non-fluorescent zones is very 
distinct in all the GUVs as seen in Figure 4.17 – E and F, which suggests the presence of lo domains. 
The overall phase behaviour of each of the mixtures studied was confirmed. Nonetheless, it can be 
advantageous to obtain an estimate of the percentage that each type of domain occupies in the GUVs 
for the two mixtures, i.e, to obtain a value that can be used to estimate the mole fraction of each phase. 
A good approach for determining this is to obtain a 3D reconstruction of the vesicles. Moreover, having 
the 3D projection allows the possibility to better analyse the different shape of the domains. By 
comparing the results for the two mixtures using the image corresponding to only one focal plane (Figure 
4.16 - C, D with Figure 4.17 – E, F) it is not very easy to distinguish between circular and non-circular 
domains. But using 3D reconstruction for the same comparison there are no doubts that the domains are 
different in shape for the two mixtures.  
 3D view of the GUVs prepared from the binary mixture DPPC/DOPC (Figure 4.16 - E) show the 
presence of a big non-round non-fluorescent region that represents around 20 % of all surface area of 
the GUV. The shape of this zone suggests what already was mentioned for the observation of two-
dimensional images, that it corresponds to a so domain. Therefore, 20 % of each of the GUVs prepared 
with the binary mixture is so domain, and 80 % is ld.  
 As for the ternary mixture (Figure 4.17 – G and H), GUVs have more than one perfectly round dark 
regions that in total make 49 % of the surface area of the GUVs. Not only the shape corresponds to the 
presence of lo domain, but also the fact that there are more than one of these circular zones confirms the 
presence of this phase. So, more than 49 % of each of the GUVs prepared with the ternary mixture of 
DPPC/DOPC/chol corresponds to lo domains, and the other 51 % is ld.  
 These values were obtained by using the Measure area tool of ImageJ which measures areas in 2D 
but in the 3D projection, which makes them only a rough estimate. A method described by Fidorra et 
al. can determine the lipid surface areas in GUVs independently on the shape of the domains127. 
However, this requires a specific software which was not available. However, since lo domains have a 
circular shape, using the mathematical approach described in the methods, it is possible to obtain a more 
rigorous estimate of the relative surface area of each domain, i.e. the percentage each domain occupies 
in the GUV, in the situation of ld-lo phase separation. Results for these calculations are in Table 4.1 
(Math).  
 Knowing the area fraction of each domain in the GUVs and the mean molecular area per lipid in 
each domain it is possible to calculate the mole fraction of each domain in the GUVs (Table 4.1. – mole 
















Table 4.1. Percentage of each domain for the GUVs prepared for binary and ternary mixtures. The values were obtained 
by using ImageJ Measure area tool (ImageJ), mathematical calculations (Math), and from literature (Lit). Values are the mean 












80 ± 1.4 
(n = 4) 
75 ± 1.7 
(n = 4) 
/ / 75* 
so 
20 ± 1.4 
(n = 4) 
25 ± 1.7 
(n = 4) 
/ / 25* 
Ternary 
ld 
51 ± 2.2 
(n = 4) 
43 ± 2.1 
(n = 4) 
55.7 ± 4.9 
(n = 12) 
47 ± 4.9 
(n = 12) 
50** 
lo 
49 ± 2.2 
(n = 4) 
57 ± 2.1 
(n = 4) 
44.3 ± 4.9 
(n = 12) 
53 ± 4.9 
(n = 12) 
50** 
* Values estimated using the tie-lines and phase diagram from 117 for DPPC/DOPC equimolar.  
** Values estimated using the tie-line and phase diagram from 116,128 for DPPC/DOPC equimolar with 






5.1. Molecular changes in LTP induced with moderate θ-burst stimulation 
5.1.1. Kv4.2 channel association with LTP modulation 
 
In this work western-blot was performed to evaluate possible molecular changes in Kv4.2 channel 
and its phosphorylation following LTP induction with a moderate TBS in hippocampal rat slices. A 
quantitative analysis revealed that LTP induction caused an increase in Kv4.2 channel expression and 
phosphorylation at Ser438, while no changes were observed for the phosphorylation at Thr607. A 
qualitative analysis of the phosphorylation at Thr602 showed no detectable phosphorylation in control 
slices however, a clear phosphorylation Kv4.2 channel was observed in θ-burst stimulated slices.  
TBS is the LTP induction stimulation pattern that better mimics the physiologically neuronal 
activity in the hippocampus during learning tasks16,17. However, depending on the intensity and duration 
of pattern of stimulation, LTP induction with TBS can be dependent on NMDA receptors and/or L-type 
voltage-dependent calcium channels16. These two forms of LTP coexist in the CA1 area of the 
hippocampus and it was suggested that each of them has independent roles in learning and memory16.  
Also, NMDA receptor-dependent LTP can be either PKA-dependent or not42. Moderate TBS, such as 
the one used in our study is NMDA receptor dependent16 but not PKA-dependent42, which is confirmed 
by previous results of our lab (Figure 1.4).  
As mentioned earlier, NMDA receptor activation leads to a Ca2+ influx that activates CaMKII. 
Enhancement of CaMKII activity can be the cause for the enhanced Kv4.2 channel phosphorylation at 
Ser438 found in this work, since phosphorylation at this residue is catalysed by CaMKII. This post-
translational modification leads to an increase in the cell-surface expression of the channel66, which can 
explain the increase of the channel levels found in this work. Since the increase of the channel expression 
leads to an increase of IA129 and consequently to the decrease of dendritic excitability, the increased 
expression of this channel does not seem to contribute to LTP expression, but rather opposing it. This 
result is in agreement with the up-regulation of dendritic Kv4.2 mRNA observed in another work, which 
was NMDA receptor- and Ca2+-dependent, indicating that Kv4.2 mRNA levels are regulated in response 
to synaptic activity130. 
Another study has showed that Kv4.2 internalization contributes to LTP induced chemically with 
glycine, and also suggest that the channel internalization contributes to LTP induced with a low 
frequency stimulation68. The phosphorylation of Kv4.2 channel at Thr602 is associated with Kv4.2 
channel internalization and IA decrease63. Therefore, the increase in the levels of phosphorylation of the 
Kv4.2 channel at Thr602 found in the present work might be contributing to LTP expression, through the 
internalization of the Kv4.2 channel that would lead to a decrease in IA.     
In this work we observed an enhancement in the Kv4.2 channel phosphorylation simultaneously at 
Ser438 and at Thr602, and the consequence previously described for each of these phosphorylations is 
opposed. However, one must consider that no differentiation between the different cellular regions of 
the membrane of the neurons was possible in this work since the whole hippocampal slice was analysed, 
and therefore each phosphorylation can be associated to different regions of the neuron. It is known that 
along the dendrites of neurons of the CA1 region of the hippocampus (pyramidal cells) the density of 
Kv4.2 channel is different60. One possible explanation for the results of this work on Kv4.2 
phosphorylation is that the regulation of the channel is different along the dendrites in response to the 
stimulation that induced LTP, i.e. in certain segments of the dendrites Kv4.2 channel may be 
phosphorylated in Ser438 and in other segments the channel may be phosphorylated in Thr602. This 
hypothesis would imply that the overall enhancement of Kv4.2 expression in response to TBS is not 
representative of the specific changes in Kv4.2 signalling at the synapse. 
Our results suggest that LTP involves regulation of Kv4.2 channel, which agrees with results that 
show that these channels modulate spatial memory formation in rats131. 
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5.1.2. PSD-95 and SNAP-25 expression was not affected by θ-burst stimulation 
 
Western-blot was also used to evaluate the levels of PSD-95 and SNAP-25 following LTP induction 
with moderate TBS in rat hippocampal slices. The levels of PSD-95 and SNAP-25 did not change 
following LTP induction. However, this does not mean that these proteins do not have a role in LTP 
expression or maintenance. 
According to Ehrlich et al. PSD-95 is not necessary for the induction and early expression of LTP, 
so no alterations in the proteins levels are expected, which agrees with the results obtained in this 
work132. However, after the expression of LTP this scaffolding protein is required for synapse 
stabilization. The mechanism suggested for this is through regulation of the AMPAR trafficking. El-
Husseini et al.  have showed that the rapid internalization of this receptor requires depalmitoylation of 
PSD-95 and suggest that regulation of the palmitate cycle on PSD-95 can regulate synaptic strength 
through changes in AMPAR trafficking upon which synaptic plasticity depends133.  
The same can be concluded in relation to SNAP-25 results. Although it has been suggested that this 
protein may be involved in memory consolidation in the CA1 region of the hippocampus134, no changes 
in its levels have been reported after LTP induction in this work. In another work, also no changes were 
detected in SNAP-25 levels following LTP induced with high-frequency stimulation (tetanic simulation) 
in the Schaffer collateral CA1 synapses135. However, LTP induction with strong TBS leads to SNAP-25 
phosphorylation75 which promotes insertion of NMDA receptors responsible for LTP expression136. This 
suggests a possible role of SNAP-25 which expression does not change but, which function can be 
regulated through fast post-translational mechanisms. This possible role of SNAP-25 can be associated 
not only with pre-synaptic vesicle fusion, but also with post-synaptic functions, since recently has been 
found that SNAP-25 is also present in postsynaptic spines, being suggested that this protein has a 
function in post-synaptic vesicle exocytosis135.      
The fact that no changes were obtained in the levels of these two proteins following LTP induction, 
that all have been in some way connected to LTP, and that following LTP induction kinases responsible 
for post-translational modification, such as CaMKII, are highly activated, suggests that the stimulation 
pattern applied in this study activates mainly rapid regulation mechanisms such as phosphorylation or 
depalmitoylation which are important to the expression and/or maintenance of LTP.   
 
5.2. Changes in lithium-pilocarpine model of TLE 
5.2.1. Neuronal death and reorganization in the dentate gyrus 
 
NeuN immunolabelling was performed to study neuronal organization in the hippocampus of rats 
showing SRSs induced with Li2+-Pilo. Results for NeuN staining were not consistent between epileptic 
rats. Overall the CA1, CA3 and the DG hilus of the hippocampus had less neurons, but statistical 
significance was only found in the DG. The DG of Epi rats also had a distinct angular shape in the 
granular cell layer. 
These differences between epileptic rats could be due to differences between seizures frequency 
and number. In fact, one of the rats that showed different neuronal pathology started to have seizures 
earlier than the others and had seizures more frequently, suggesting that progression of the disease was 
faster in this animal, thus leading to more damage. Moreover, recent evidence showed that neuronal 
survival correlates negatively with seizure frequency137.  
Also, Nissl-staining method was performed, and showed that the CA1 area of the hippocampus of 
epileptic rats, had less cells than control rats and the granular cell layer of the DG had an angular shape.   
Neuronal death in the hilus of the DG area of the hippocampus detected for all the rats in NeuN-
labelling results characterizes TLE, alongside a not so highlighted neuronal loss in the pyramidal cell 
layer of the CA1 and CA3 area138,139.  
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Neuronal death in the hilus can be the cause of the angular shape found for the granular cell layer 
observed in the DG for all epileptic rats with both NeuN immuolabelling and Nissl-staining. The loss of 
hilar neurons could lead to the collapse of the granular cell layer of the DG to the interior (in the direction 
of the CA3) as seen in the results of this work.  
Timm-staining results show that epileptic rats had higher staining than Sham rats, especially in the 
granular cell layer of the DG and in the CA4 area, but also in CA1 and CA3 areas. This higher staining 
indicates that mossy fiber (the axons granule cells) sprouting occurred in the DG. It is proposed that 
neuronal loss in the hilus of the DG area of the hippocampus (also observed in the present work), leads 
to this mossy fiber sprouting and re-innervation of new regions of the DG140. Higher mossy fiber 
sprouting is also found in the DG of both human TLE patients 140,141 and in several rat models of 
TLE142,143, and it is thought to underlie the creation of aberrant circuitry which promotes the generation 
and/or spread of SRSs143.  
 
5.2.2. AMPA receptor subunit regulation leads to hyperexcitability that characterizes TLE 
 
Evaluation of the AMPAR composition in isolated hippocampal membranes of rats showing SRSs 
revealed that the AMPAR subunits GluA1 and GluA2 levels decreased, and the GluA1/GluA2 ratio 
increased. Also, an increase in the phosphorylation of GluA1 in Ser831 and Ser845 residues was observed.  
Eight weeks following SE induction with KA, a down-regulation of GluA2 subunit is observed in 
rats hippocampus96, a result that agrees with the decrease of GluA2 here described.  
Lopes et al. have shown that 50 days after SE induced with pilocarpine GluA1 levels do not 
change55 in the hippocampus of rats, which is not agreement with our observation of decreased GluA1 
levels. In the same work no changes in GluA1 phosphorylation in Ser831 are detected while, the level of 
hippocampal GluA1 phosphorylation at Ser845 is decreased 8. The same group described that 60 days 
after SE induced in rats with pilocarpine, GluA1 phosphorylation on Ser845 was decreased in the dorsal 
hippocampus, while GluA1 in the ventral hippocampus was instead less phosphorylated in Ser831 
residue. Those results are not in agreement with what was found in this work: an enhancement in GluA1 
phosphorylation in Ser831 and Ser845. However, in our study, rats are also in a chronic phase of the 
disease, not only with 50 days after SE, but 9 months after SE induced with Li2+-Pilo. This suggests that 
there are differences in GluA1 phosphorylation along the chronic period in SRS rats, i.e., with the 
progression of the disease.  
The increase in the phosphorylation of GluA1 at Ser845 observed in this work, suggests that an 
increase of the open probability of the channel of AMPAR and in the recruitment of this receptor from 
intracellular compartments to the extra-synaptic region. In addition, Ser831 phosphorylation leads to an 
increase of the conductance state of the AMPAR and of the recruitment of the receptor to the synaptic 
region. These relations suggest that, overall, in the chronic period of TLE, there are more AMPARs in 
the synaptic region with channels in higher conductance states. This leads to the existence of larger 
EPSPs, and consequently, neurons are easier to stimulate. So, these post-translational modifications 
possibly contribute to the disease. Since PKA is the only known kinase that catalyses phosphorylation 
in Ser845, this result suggests that this kinase has a higher activity and/or a role in the chronic period of 
TLE. However, for phosphorylation in Ser831, there are two possible enzymes that catalyse the 
modification: CaMKII and PKC; which makes it unpredictable which one of the two, or even if both 
these enzymes have higher activity in this model of TLE.  
The increase in GluA1/GluA2 ratio found in this work, suggests that the pool of GluA2-lacking 
receptors is increased in rats with SRSs. This pool is permeable to Ca2+, which hints that there is a higher 
influx of Ca2+ following depolarization, that can both activate kinases, such as CaMKII and increase the 
excitability of the neurons thus leading to excitotoxicity and contributing to the progression of the 
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disease. The present work was the first to study the GluA1/GluA2 ratio in the chronic period of rodent 
models of TLE.  
Probably, the enhancement in GluA1 phosphorylation in Ser831 and Ser845 and the increase in the 
number of Ca2+-permeable AMPARs, happens at the same time, or at time scales that are not 
distinguishable, as a result from overly excitation of the neurons that occurs during seizures. This in turn 
leads also to Ca2+ influx through, among other, NMDA receptors96. This influx activates kinases, such 
as CaMKII and PKA, that regulate, the interaction of the receptor with associated proteins that modulate 
the membrane trafficking and synaptic targeting of the AMPARs144. This NMDA receptor and PKA 
dependent mechanism agrees with what is seen in LTP induced with high frequency stimulation 
patterns42,47. 
 
5.2.3. PSD-95 and gephyrin expression is altered in the chronic period of TLE: a new adaptive 
mechanism that guarantees animal survival? 
 
In this work, the PSD-95 and gephyrin levels showed opposite changes in the model of chronic 
period of TLE studied: PSD-95 expression decreased while gephyrin expression increased. These results 
were maintained when the levels of PSD-95 and gephyrin were normalized to the variation the levels of 
SNAP-25, taken as a marker of the total number of synapses, i. e., the ratio of PSD-95 to SNAP-25 
expression decreases, while the ratio of gephyrin to SNAP-25 levels increases.  
A decrease in the levels of PSD-95 was also observed in a previous study in the hippocampus of 
rats 4 to 6 weeks after SE was induced with KA10. 
Immunohistochemistry studies from Fang et al. (2011) show that gephyrin levels are decreased in 
the hippocampus of rats in the latent and chronic period of TLE, from 24 hours to 2 months after the 
first grade of seizures induced with Li2+-Pilo89. This decrease in gephyrin does not agree with the 
increase found in our work, however, this difference is probably due to the fact that our study was 
performed 9 months after SE, while in the work of Fang et al. the study is conducted 24 hours to 2 
months after SE was induced, an early stage of the disease. Also, in the present work Wistar rats were 
used, while the work of Fang et al. was conducted using Sprague-Dawley.  
PSD-95 is a scaffolding PSD protein that promotes maturation and strengthening of excitatory 
synapses145 and regulates AMPAR trafficking in vitro and in vivo79,146–148. These roles lead to regulation 
of synaptic strength such as the ones that underlie synaptic plasticity mechanisms. Taking this into 
account, the decrease found in PSD-95 levels will consequently lead to a dampening of excitatory 
synapses, reducing neuronal excitability.  
Gephyrin controls the number of postsynaptic GABAA receptors88 and its recruitment to the PSD 
leads to the immobilization of GABAA receptors at synapses149. These receptors mediate inhibitory 
transmission, so an increase in gephyrin, likely reflects an increase in synaptic targeting of GABAA 
receptors and consequent increase in inhibitory transmission, that may have a role in the control of 
excessive pyramidal/principal cell excitability in TLE.  
The change in gephyrin and PSD-95 levels here reported suggest that this alteration must be an 
adaptative mechanism that neurons have to reduce the hyperexcitability imposed by other molecular 
mechanism such as the ones mentioned in the previous chapter (5.2.2) that involved AMPAR, i.e. a 
neuronal protection to the excitotoxic conditions. 
 
5.2.4. Kv4.2 channel is not changed in the chronic period of TLE 
 
No significant difference on the Kv4.2 channel levels were found in the chronic period of the Li2+-
Pilo rat model of TLE when compared with the controls. In a previous study, 50 days after SE induced 
in rats with Li2+-Pilo, a decrease in the Kv4.2 channel was observed in the hippocampus11, which is not 
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in agreement with our results. However, as already discussed in a previous chapter (5.2.2), since our rats 
were studied 9 months (270 days) after SE induction, and not 50 days, there may be differences along 
the chronic period of TLE in the expression of this channel.  
It is important to note that the dispersion of the results for SRS rats was very large, influencing the 
result for the Kv4.2 channel. A non-statistical analysis by simple observation suggests that the Kv4.2 
channel levels tend to increase. A confirmation of these results would require an increase in the number 
of the samples probed for this channel. 
 
5.2.5. Temporal lobe epilepsy and lipid rafts 
 
In this work we have shown that caveolin-1 levels are increased in hippocampal membranes of rats 
with SRSs, but flotillin-1 levels did not change. This was the first time that the level of proteins that are 
associated with lipid rafts, flotillin-1 and caveolin-1 was studied in the context of TLE.   
Whether the increase of caveolin-1 found in this work constitutes an additional mechanism of 
neuronal protection, to counteract hyperexcitability, or is itself contributing to the disease would require 
extending the studies in the present work. However, one may wonder what is changed with the alteration 
in this protein. In neurons, caveolin is involved in trafficking of signalling complexes, neuronal 
differentiation, regulation of neurotransmitter binding106, and neuroprotection150,151. Caveolin-1 can 
inhibit the binding of ligands to AMPARs by inhibiting phospholipase A2109. This enzyme, when 
activated, can change the lipid environment of AMPARs increasing its affinity to ligands109. It is possible 
that the high neuronal influx on Ca2+ that characterizes repeated firing and depolarization in TLE can 
activates this enzyme leading to higher AMPARs affinity for glutamate, that in turn may contribute to 
hyperexcitability. Considering this possibility, and the role of caveolin in neuroprotection, the 
enhancement in caveolin-1 levels in the hippocampus of rats with SRSs, reported in this work could be 
another neuronal protective mechanism, by promoting inhibition phospholipase A2, and consequently 
neuronal excitability.  
As for flotillin-1, a planar lipid raft associated protein, its levels did not change in the hippocampus 
of rats with SRSs. Swanwick et al. have shown through immunocytochemical and electrophysiological 
assays that flotillin-1 promotes the formation of glutamatergic, but not GABAergic, synapses in the 
hippocampus152. As suggested by the authors, flotillin-1 enhances the formation of glutamatergic 
synapses probably by accelerating dendritic spine formation and maturation, since it induces filopodia 
formation152. PSD proteins are highly connected with lipid rafts, e.g. PSD-95. The increase of PSD-95 
and flotillin-1 separately increases glutamatergic transmission. Furthermore, raft depletion reduces the 
density of PSD-95 along dendrites153. No significant changes were found for flotillin-1 levels in the 
chronic period of TLE, probably because of the high error associated with the results, associated to poor 
antibody staining. If statistics are not considered, the levels of the protein seem to decrease in diseased 
animals. If this is true, then it suggests that, due to flotillin-1 role in promoting glutamatergic synapse 
formation, this decrease is contributing to reduce glutamatergic transmission. This would again suggest 
a neuroprotective role for flotillin-1 in the chronic period of TLE, alongside caveolin-1, PSD-95 and 
gephyrin. However, enhancing the size of the sample with a more sensitive antibody would be important 
to accurately address this question.  
 
5.3. GUV preparation by electroformation was optimized 
 
GUVs observation and preparation with artificial mixtures by the electroformation method was 
successfully achieved in this work. 
The number of GUVs prepared from the DPPC/DOPC/chol mixture was larger and produced bigger 
GUVs than the ones obtained with the DPPC/DOPC mixture. This is probably due to the presence of 
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the gel domain, that in the binary mixture decreases the GUV stability, or renders their formation more 
difficult, hence the smaller number of GUVs obtained for this mixture.    
The mole fraction of each phase in the GUVs prepared with the binary mixture estimated with visual 
cues was equal to the one obtained by other studies using tie-lines and phase diagrams117. For the ternary 
mixture, the mole fraction of each phase estimated with both the visual cues and through a mathematical 
approach was very close to what is found in literature116,128, with the mathematical approach having 
closer values. This suggests that both methods used are good approaches to estimate phase coexistence, 




6. Conclusion and future perspectives 
 
This work characterized the hippocampal membranes of a rat SRS model of TLE obtained by the 
lithium-pilocarpine injection procedure. In this model it was observed that: 
• The dentate gyrus suffers more damage than the other hippocampal regions; 
• An enhancement of AMPAR GluA1 subunit phosphorylation and changes in AMPAR subunit 
composition leads to hyperexcitability that characterizes TLE, contributing to the maintenance 
of the disease; 
• PSD-95 levels are decreased and gephyrin expression is enhanced in a way that is consistent 
with a role in promoting animal neuroprotection from excessive neuronal activity; 
• Caveolin-1 expression is enhanced suggesting an involvement of lipid raft changes in the 
disease, which is probably also neuroprotective; 
• There are likely changes along the timeline of the chronic period of TLE in the expression of 
several synaptic/molecular markers. 
 
In this work it was also studied the possible role of Kv4.2 channel phosphorylation, in the expression 
of LTP induced with a moderate θ-burst stimulation. It was concluded that modulation of the Kv4.2 
channel has a role in LTP induced with a moderate θ-burst stimulation, through phosphorylation in Ser438 
and Thr602 but not in Thr607.   
 
Although the present work has demonstrated some molecular mechanisms that underlie both LTP 
expression and synaptic and molecular membrane changes in TLE, more studies are needed to fully 
understand their precise role in disease pathology. An important study would be to have different rats 
along the timeline of the lithium-pilocarpine model, i.e. to study the SE, the latent period and the chronic 
period of this TLE model, in each of the different regions of the hippocampus and in the temporal cortex, 
regarding the levels of the same proteins approached in this work, and their phosphorylation and 
palmitoylation. Also, using the same timeline approach, the presence of lipid rafts and their stability in 
the disease needs to be studied, to better understand how the change found for caveolin-1 expression 
could be related to TLE. One possible study is the analysis of GUVs prepared with lipids extracted from 
lithium-pilocarpine and Sham rats synaptosomes, together with lipidomic studies. This type of approach 
would be important to unravel the molecular changes that happen along the progression of the disease, 
and define differences between epileptogenesis, its consequence along time and the adaptive 
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8.1. Calibration curves for the Bradford method 
 
 
Figure 8.1. Calibration curve for the Bradford method120, for determination of protein concentration of C and θ 
samples. The dashed line represents the linear adjustment for the ratio of the absorbances read at 590 nm and 450 nm obtained 
for each protein concentration. R2 is the coefficient of determination, which reflects the quality of the linear regression (the 
closer to 1 the better the adjustment).  
 
 
Figure 8.2. Calibration curve for the Bradford method120 for determination of protein concentration of Sham and Epi 
samples. The dashed line represents the linear adjustment for the ratio of the absorbances read at 590 nm and 450 nm obtained 















































































8.2. Calibration curve for the Rouser method 
 
 
Figure 8.3. Calibration curve for the phospholipid quantification by Rouser method 122, used to quantify DPPC and 
DOPC. The dashed line represents the linear fit for the three replicates obtained for each phosphate (Pi) quantity. R2 is the 
coefficient of determination.  
 
8.3. Rhod-DOPE absorption spectrum 
 
   
Figure 8.4. Absorption spectrum of Rhod-DOPE in chloroform at room temperature. The maximum of absorbance occurs 
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